<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Antibiotics (Basel)</journal-id><journal-id journal-id-type="iso-abbrev">Antibiotics (Basel)</journal-id><journal-id journal-id-type="publisher-id">antibiotics</journal-id><journal-title-group><journal-title>Antibiotics</journal-title></journal-title-group><issn pub-type="epub">2079-6382</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4790380</article-id><article-id pub-id-type="doi">10.3390/antibiotics3040540</article-id><article-id pub-id-type="publisher-id">antibiotics-03-00540</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Resistance to Antimicrobial Peptides in Vibrios</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Destoumieux-Garz&#x000f3;n</surname><given-names>Delphine</given-names></name><xref ref-type="aff" rid="af1-antibiotics-03-00540">1</xref><xref rid="c1-antibiotics-03-00540" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Duperthuy</surname><given-names>Marylise</given-names></name><xref ref-type="aff" rid="af2-antibiotics-03-00540">2</xref></contrib><contrib contrib-type="author"><name><surname>Vanhove</surname><given-names>Audrey Sophie</given-names></name><xref ref-type="aff" rid="af1-antibiotics-03-00540">1</xref></contrib><contrib contrib-type="author"><name><surname>Schmitt</surname><given-names>Paulina</given-names></name><xref ref-type="aff" rid="af3-antibiotics-03-00540">3</xref></contrib><contrib contrib-type="author"><name><surname>Wai</surname><given-names>Sun Nyunt</given-names></name><xref ref-type="aff" rid="af2-antibiotics-03-00540">2</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Shafer</surname><given-names>William M.</given-names><prefix>Dr.</prefix></name><role>External Editor</role></contrib></contrib-group><aff id="af1-antibiotics-03-00540"><label>1</label>Ecology of Coastal Marine Systems, CNRS, Ifremer, University of Montpellier, IRD, Place Eug&#x000e8;ne Bataillon, CC80, 34095 Montpellier, France; E-Mail: <email>avanhove@univ-montp1.fr</email></aff><aff id="af2-antibiotics-03-00540"><label>2</label>Department of Molecular Biology, The Laboratory for Molecular Infection Medicine Sweden (MIMS), Ume&#x000e5; University, 901 87 Ume&#x000e5;, Sweden; E-Mails: <email>marylise.duperthuy@molbiol.umu.se</email> (M.D.); <email>sun.nyunt.wai@molbiol.umu.se</email> (S.N.W.)</aff><aff id="af3-antibiotics-03-00540"><label>3</label>Laboratorio de Gen&#x000e9;tica e Inmunolog&#x000ed;a Molecular, Instituto de Biolog&#x000ed;a, Pontificia Universidad Cat&#x000f3;lica de Valpara&#x000ed;so, Avenida Universidad 330, 2373223 Valpara&#x000ed;so, Chile; E-Mail: <email>paulina.schmitt@ucv.cl</email></aff><author-notes><corresp id="c1-antibiotics-03-00540"><label>*</label>Author to whom correspondence should be addressed; E-Mail: <email>ddestoum@univ-montp2.fr</email>; Tel.: +33-467-144-625; Fax: +33-467-144-622.</corresp></author-notes><pub-date pub-type="epub"><day>27</day><month>10</month><year>2014</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2014</year></pub-date><volume>3</volume><issue>4</issue><fpage>540</fpage><lpage>563</lpage><history><date date-type="received"><day>16</day><month>9</month><year>2014</year></date><date date-type="rev-recd"><day>25</day><month>9</month><year>2014</year></date><date date-type="accepted"><day>08</day><month>10</month><year>2014</year></date></history><permissions><copyright-statement>&#x000a9; 2014 by the authors; licensee MDPI, Basel, Switzerland.</copyright-statement><copyright-year>2014</copyright-year><license><license-p><!--CREATIVE COMMONS-->This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Vibrios are associated with a broad diversity of hosts that produce antimicrobial peptides (AMPs) as part of their defense against microbial infections. In particular, vibrios colonize epithelia, which function as protective barriers and express AMPs as a first line of chemical defense against pathogens. Recent studies have shown they can also colonize phagocytes, key components of the animal immune system. Phagocytes infiltrate infected tissues and use AMPs to kill the phagocytosed microorganisms intracellularly, or deliver their antimicrobial content extracellularly to circumvent tissue infection. We review here the mechanisms by which vibrios have evolved the capacity to evade or resist the potent antimicrobial defenses of the immune cells or tissues they colonize. Among their strategies to resist killing by AMPs, primarily vibrios use membrane remodeling mechanisms. In particular, some highly resistant strains substitute hexaacylated Lipid A with a diglycine residue to reduce their negative surface charge, thereby lowering their electrostatic interactions with cationic AMPs. As a response to envelope stress, which can be induced by membrane-active agents including AMPs, vibrios also release outer membrane vesicles to create a protective membranous shield that traps extracellular AMPs and prevents interaction of the peptides with their own membranes. Finally, once AMPs have breached the bacterial membrane barriers, vibrios use RND efflux pumps, similar to those of other species, to transport AMPs out of their cytoplasmic space.</p></abstract><kwd-group><kwd>vibrio</kwd><kwd>lipopolysaccharide</kwd><kwd>outer membrane vesicle</kwd><kwd>membrane transporter</kwd><kwd>innate immunity</kwd><kwd>defensin</kwd><kwd>cathelicidin</kwd><kwd>bactericidal/permeability-increasing protein</kwd></kwd-group></article-meta></front><body><sec><title>1. Introduction</title><p>Vibrios are &#x003b3;-proteo-bacteria ubiquitous in aquatic environments. They have evolved the capacity to colonize a broad series of hosts from protozoans to metazoans. Vibrios are normally present in the tissues of healthy animals. Sometimes they become pathogenic in wild marine animals such as corals, in particular as a result of environmental changes including shifts in seawater temperature and salinity, or, for aquacultured animals, upon exposure to high animal densities or stressful farming practices [<xref rid="B1-antibiotics-03-00540" ref-type="bibr">1</xref>]. Currently, vibrioses are recognized as a major factor limiting the development of aquaculture. In addition, vibrios can cause severe disease outbreaks in human populations, the best known example being cholera. Again, environmental drivers&#x02014;such as temperature changes, severe rainfalls that lower water salinity, and insufficient sanitation&#x02014;govern the occurrence of the disease in human populations [<xref rid="B2-antibiotics-03-00540" ref-type="bibr">2</xref>].</p><p>Vibrios have developed tropism for epithelial tissues that line both the outside and inside of cavities and lumen of their diverse hosts. They can colonize the keratinized epithelium of skin as well as the gastrointestinal tract. By lining the cavities and surfaces of structures throughout the body, epithelia act as a first line of defense against pathogens. Epithelia also produce antimicrobial peptides (AMPs) [<xref rid="B3-antibiotics-03-00540" ref-type="bibr">3</xref>,<xref rid="B4-antibiotics-03-00540" ref-type="bibr">4</xref>], conferring to the host an immune arsenal broadly conserved among metazoans. When the host's epithelial barriers are breached, vibrios encounter phagocytes, key components of the animal immune system. These phagocytes infiltrate infected tissues and use reactive oxygen and nitrogen species (ROS and RNS) as well as AMPs to kill phagocytosed microorganisms intracellularly or deliver their antimicrobial content extracellularly to circumvent infection. Interestingly, recent works have shown that vibrios are able to colonize and survive inside phagocytes [<xref rid="B5-antibiotics-03-00540" ref-type="bibr">5</xref>,<xref rid="B6-antibiotics-03-00540" ref-type="bibr">6</xref>].</p><p>AMPs from metazoans are often cationic peptides that initially interact electrostatically with the membranes of bacteria, which carry negatively-charged lipopolysaccharide (Gram-negative) or teichoic acids (Gram-positive). Many AMPs then insert into the membranes and form deleterious pores or channels [<xref rid="B7-antibiotics-03-00540" ref-type="bibr">7</xref>]. Alternatively, AMPs can bind to essential components of bacterial membranes or translocate across to reach the cytoplasm, where they interfere with essential cellular processes such as nucleic acid, protein, enzyme, and cell wall syntheses [<xref rid="B8-antibiotics-03-00540" ref-type="bibr">8</xref>,<xref rid="B9-antibiotics-03-00540" ref-type="bibr">9</xref>,<xref rid="B10-antibiotics-03-00540" ref-type="bibr">10</xref>,<xref rid="B11-antibiotics-03-00540" ref-type="bibr">11</xref>,<xref rid="B12-antibiotics-03-00540" ref-type="bibr">12</xref>,<xref rid="B13-antibiotics-03-00540" ref-type="bibr">13</xref>]. In addition, AMPs produced by a given host can be synergistic, combining their mechanisms of action to fight bacterial pathogens [<xref rid="B14-antibiotics-03-00540" ref-type="bibr">14</xref>]. However, it has become clear that the activity of AMPs goes far beyond their antimicrobial properties; these peptides are also involved in many immunomodulatory functions including inflammation, wound healing, chemotaxis, cell differentiation, angiogenesis, regulation of oxidative stress, regulation of adaptive immunity, and epithelia homeostasis [<xref rid="B4-antibiotics-03-00540" ref-type="bibr">4</xref>,<xref rid="B15-antibiotics-03-00540" ref-type="bibr">15</xref>]. Accordingly, AMPs are also called Host Defence Peptides.</p><p>Importantly, the tissues of healthy metazoans host an abundant microbiota, which itself has the capacity to produce AMPs, contributing to protection against pathogenic microbes. Prokaryotic AMPs are frequently referred to as bacteriocins, a generic name that covers classes of compounds with diverse structures and mechanisms of action. Bacteriocins may be peptides created by complex biosynthetic pathways that enable the inclusion of unconventional amino acids, as well as nucleotides and siderophores [<xref rid="B16-antibiotics-03-00540" ref-type="bibr">16</xref>,<xref rid="B17-antibiotics-03-00540" ref-type="bibr">17</xref>]. Many of these prokaryotic AMPs are cationic, although this is not a general rule. Like metazoan AMPs, some target the bacterial membranes while others target specific receptors and behave as inhibitors of key metabolic pathways. Still others combine different mechanisms of action (for review see [<xref rid="B17-antibiotics-03-00540" ref-type="bibr">17</xref>]).</p><p>When confronted with such a complex immune arsenal, how do vibrios avoid the chemical defenses of their hosts and associated microbiota? What can we learn from their ability to colonize immune cells/tissues that produce high local concentrations of AMPs? In the context of the extensive antibiotic use that has led to emergence of broad-spectrum antibiotic-resistant bacteria [<xref rid="B18-antibiotics-03-00540" ref-type="bibr">18</xref>], AMPs are often seen as an alternative to conventional antibiotics. However, an increasing number of studies have shown the diversity of mechanisms by which bacteria can also avoid the action of AMPs. Thus, the emergence of &#x0201c;superbugs&#x0201d; resistant to both antibiotics and AMPs is a potential risk of using AMPs as an antibiotic alternative. However, understanding the mechanism by which bacteria have evolved the capacity to live in AMP-producing tissues should allow us to develop strategies to prevent AMP-resistance.</p></sec><sec><title>2. Antimicrobial Peptides in Host-Vibrio Interactions</title><sec><title>2.1. Vibrios Colonizing Epithelial Surfaces</title><p>Many species of vibrios pathogenic for human and animal species have evolved the capacity to colonize epithelia (<xref ref-type="table" rid="antibiotics-03-00540-t001">Table 1</xref>). Among these, the species of vibrios pathogenic for humans, <italic>Vibrio</italic><italic>cholerae</italic> and <italic>Vibrio parahaemolyticus,</italic> cause major enteric disorders. While <italic>V. parahaemolyticus</italic> disrupts the intestinal epithelium [<xref rid="B19-antibiotics-03-00540" ref-type="bibr">19</xref>], <italic>V. cholerae</italic> induces inflammatory responses and innate immune cell infiltration in the small intestine without affecting the integrity of the mucosal tissue [<xref rid="B20-antibiotics-03-00540" ref-type="bibr">20</xref>]. Diarrhea caused by such enteric infections leads to intense dehydration and is recognized as a major factor in morbidity and mortality worldwide. Virulence factors of the diarrheagenic vibrios are expressed upon intimate association with host epithelial cells and, in many instances, include the secretion of toxins. Vibrios causing gastrointestinal infection need to penetrate the mucous layer before attaching to intestinal epithelial cells, a process usually mediated by fimbriae or pilus structures (e.g., toxin-co-regulated pilus (TCP)). Subsequently, the bacteria secrete important virulence factors such as cholera toxin (CT) and hemagglutinin/protease (HA/protease) (for review see [<xref rid="B21-antibiotics-03-00540" ref-type="bibr">21</xref>]). In <italic>V. parahaemolyticus</italic>, colonization of the intestine is dependent on the type III secretion system (T3SS2) [<xref rid="B22-antibiotics-03-00540" ref-type="bibr">22</xref>] and further secretion of a T3SS2-secreted effector, VopZ, which also inhibits host mucosal defenses [<xref rid="B23-antibiotics-03-00540" ref-type="bibr">23</xref>].</p><p>As in humans, many vibrios colonize the epithelial surfaces of animals, both vertebrates and invertebrates. Again, this often requires a first step of binding to the mucus covering the epithelium. In some cases, epithelium colonization is part of a mutualistic process. For instance, in the squid, the luminescent <italic>Vibrio fischeri</italic> colonizes the crypts of the squid light organ, which consists of a series of deep invaginated epithelium-lined crypt spaces [<xref rid="B24-antibiotics-03-00540" ref-type="bibr">24</xref>]. In other cases, invasion of the epithelium is part of the pathogenic process. For instance, in the rainbow trout, <italic>Vibrio anguillarum</italic> colonizes both the skin and the intestinal epithelia, causing a fatal hemorrhagic septicaemia [<xref rid="B25-antibiotics-03-00540" ref-type="bibr">25</xref>]. Similarly, in the coral <italic>Oculina Patagonica</italic>, the pathogenic <italic>Vibrio shiloi</italic> penetrates into the epithelial cells of the coral, multiplies, and produces a toxin that inhibits photosynthesis of the coral symbiotic algae (for review see [<xref rid="B26-antibiotics-03-00540" ref-type="bibr">26</xref>]).</p><table-wrap id="antibiotics-03-00540-t001" position="float"><object-id pub-id-type="pii">antibiotics-03-00540-t001_Table 1</object-id><label>Table 1</label><caption><p>Vibrios colonizing epithelia.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Species or strain</th><th align="left" valign="top" rowspan="1" colspan="1">Host</th><th align="left" valign="top" rowspan="1" colspan="1">Tissues</th><th align="left" valign="top" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic>V. cholerae</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">human</td><td align="left" valign="top" rowspan="1" colspan="1">intestine</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="B20-antibiotics-03-00540" ref-type="bibr">20</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic>V. vulnificus</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">human</td><td align="left" valign="top" rowspan="1" colspan="1">skin, wounds</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="B27-antibiotics-03-00540" ref-type="bibr">27</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic>V. parahemolyticus</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">human</td><td align="left" valign="top" rowspan="1" colspan="1">intestine</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="B19-antibiotics-03-00540" ref-type="bibr">19</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic>V. anguillarum</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">fish</td><td align="left" valign="top" rowspan="1" colspan="1">skin, intestine</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="B25-antibiotics-03-00540" ref-type="bibr">25</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic>V. shiloi</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">coral</td><td align="left" valign="top" rowspan="1" colspan="1">oral ectoderm</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="B26-antibiotics-03-00540" ref-type="bibr">26</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic>V. coralliilyticus</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">coral</td><td align="left" valign="top" rowspan="1" colspan="1">oral ectoderm</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="B28-antibiotics-03-00540" ref-type="bibr">28</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic>V. fisheri</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">squid</td><td align="left" valign="top" rowspan="1" colspan="1">light organ</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="B24-antibiotics-03-00540" ref-type="bibr">24</xref>]</td></tr></tbody></table></table-wrap></sec><sec><title>2.2. AMPs and Epithelial Defenses</title><p>Mammalian epithelial tissues such as the epidermis but also the respiratory, gastrointestinal and genitourinary tracts are in direct contact with the environment, thus, constant interaction between microorganisms and the immune system occurs at these sites. In vertebrates, epithelial tissues provide the first line of protection as they trigger the immune response. Mammalian epithelial cells function as both a physical barrier and as immune active cells, producing a number of immune-related molecules [<xref rid="B29-antibiotics-03-00540" ref-type="bibr">29</xref>]. Therefore, colonizing vibrios face a diversity of chemical weapons expressed in epithelial tissues. Indeed, in animals, virtually all epithelia have been found to express AMPs either constitutively or in response to damage and/or infection (<xref ref-type="table" rid="antibiotics-03-00540-t002">Table 2</xref>).</p><p><italic><bold>In humans</bold></italic>, AMPs are expressed in a broad range of epithelial cell types, either constitutively or in response to infection. The major AMPs and proteins of human epithelia include the small cationic &#x003b1;- and &#x003b2;-defensins, the human cathelicidin LL-37 (hCAP-18) and the bactericidal/permeability-increasing protein (BPI). The average concentration of defensins in these epithelial cells reaches the 10&#x02013;100 &#x000b5;g/mL range with higher local concentrations due to the uneven distribution of defensins [<xref rid="B3-antibiotics-03-00540" ref-type="bibr">3</xref>]. BPI is expressed in mucosal epithelia including the esophagus and the colon [<xref rid="B30-antibiotics-03-00540" ref-type="bibr">30</xref>]. LL-37 is expressed in the squamous epithelia of the airways, mouth, tongue, esophagus and large intestine [<xref rid="B31-antibiotics-03-00540" ref-type="bibr">31</xref>,<xref rid="B32-antibiotics-03-00540" ref-type="bibr">32</xref>,<xref rid="B33-antibiotics-03-00540" ref-type="bibr">33</xref>] as well as in inflamed skin [<xref rid="B34-antibiotics-03-00540" ref-type="bibr">34</xref>]. Human &#x003b2;-defensins are expressed by kidney, skin, pancreas, gingiva, tongue, esophagus, salivary gland, cornea, and airway epithelium [<xref rid="B35-antibiotics-03-00540" ref-type="bibr">35</xref>]. In the small intestine, the antimicrobial C-type lectins HIP/PAP are expressed [<xref rid="B4-antibiotics-03-00540" ref-type="bibr">4</xref>,<xref rid="B36-antibiotics-03-00540" ref-type="bibr">36</xref>] together with enteric &#x003b1;-defensins, which are major AMPs exclusively expressed by Paneth cells located at the bottom of the intestinal crypts [<xref rid="B37-antibiotics-03-00540" ref-type="bibr">37</xref>]. Importantly, the epithelial lining of the small intestine is the site at which <italic>V. cholerae</italic> adheres after passing through the gastric acid barrier and penetrating the mucin layer of the small intestine [<xref rid="B38-antibiotics-03-00540" ref-type="bibr">38</xref>].</p><p>The human enteric &#x003b1;-defensins HD-5 and HD-6 are components of the secretory granules of Paneth cells. They are released in the lumen of the small intestinal crypts upon exposure to bacteria and bacterial antigens. Their contribution to enteric mucosal immunity has been clearly evidenced in transgenic mice expressing the human Paneth cell &#x003b1;-defensin, HD-5 [<xref rid="B39-antibiotics-03-00540" ref-type="bibr">39</xref>]. While HD-5 has direct antimicrobial activity against bacteria, HD-6 acts by creating nanonets that entrap bacteria and prevent further dissemination [<xref rid="B40-antibiotics-03-00540" ref-type="bibr">40</xref>]. Paneth cells of mice also secrete their own &#x003b1;-defensins into the lumen of small intestinal crypts, and local concentrations have been estimated to be 25&#x02013;100 mg/mL at the point of release [<xref rid="B37-antibiotics-03-00540" ref-type="bibr">37</xref>]. Paneth cells were also shown to express LPLUNC1 which co-localizes with HD-5 in the secretory granules. LPLUNC1 is a protein similar to BPI which does not display antimicrobial activity <italic>in vitro</italic> but binds lipopolysaccharide (LPS) and inhibits the TLR4-signaling pathway in response to <italic>V. cholerae</italic> O1 LPS. LPLUNC1 mRNA is also the most highly up-regulated transcript in the small intestine during acute phase cholera [<xref rid="B41-antibiotics-03-00540" ref-type="bibr">41</xref>].</p><p><italic><bold>In fish</bold></italic>, epithelial defenses include a series of AMPs whose expression varies according to peptide families, fish species and tissues (for recent reviews see [<xref rid="B42-antibiotics-03-00540" ref-type="bibr">42</xref>,<xref rid="B43-antibiotics-03-00540" ref-type="bibr">43</xref>]). Indeed, fish AMPs are abundant in mucosal linings such as the skin, gills, and intestine, suggesting an important role in immunity [<xref rid="B44-antibiotics-03-00540" ref-type="bibr">44</xref>]. These include AMPs similar to those found in mammals, namely &#x003b2;-defensins, cathelicidins, hepcidins and histone-derived AMPs together with &#x003b1;-helical peptides AMPs (pleurocidin, piscidins, and moronecidin, among others). Fish &#x003b2;-defensin genes have the highest basal expression in skin epithelium, which is induced by a variety of bacterial challenges such as <italic>Aeromonas hydrophila</italic> and <italic>Vibrio anguillarum.</italic> Interestingly, tissue-specific production of &#x003b2;-defensins has been described in salmonids where variants of this family can be differentially up-regulated in the intestine or gill tissues following bacterial challenge [<xref rid="B45-antibiotics-03-00540" ref-type="bibr">45</xref>]. Hepcidin, which is both an AMP and a hormone expressed in liver, is also expressed by the skin epithelium and intestine. Fish hepcidin genes can be induced by exposure to both Gram-positive and Gram-negative bacteria. Cathelicidin is expressed in diverse epithelia including skin, gill and intestine. In the Atlantic cod, its expression in the gills was induced by <italic>Aeromonas salmonicida</italic> but not by <italic>V. anguillarum</italic> [<xref rid="B46-antibiotics-03-00540" ref-type="bibr">46</xref>]. Like &#x003b2;-defensins, salmonid cathelicidins are produced in several mucosal tissues where variants display differential expression [<xref rid="B47-antibiotics-03-00540" ref-type="bibr">47</xref>]. Moreover, transcripts of a homologue of the human bactericidal/permeability-increasing protein (BPI) have been found in the skin, intestine and gills of various fish species [<xref rid="B48-antibiotics-03-00540" ref-type="bibr">48</xref>,<xref rid="B49-antibiotics-03-00540" ref-type="bibr">49</xref>]. Finally, histone-derived AMPs are released in the epithelial mucosal layer of wounded fish skin [<xref rid="B50-antibiotics-03-00540" ref-type="bibr">50</xref>]; they are expressed by mucus-producing globlet cells, the cells in which all the AMPs from fish skin accumulate [<xref rid="B43-antibiotics-03-00540" ref-type="bibr">43</xref>].</p><p><italic><bold>In marine invertebrates</bold></italic>, AMPs are also expressed by a broad range of epithelial cell types. Homologues of human BPI are produced by diverse invertebrate species. In the squid <italic>Euprymna scolopes</italic>, <italic>Es-</italic>LBP1 was found in the light organ of juvenile squids colonized by <italic>V. fischeri</italic>, but not in aposymbiotic squids. Expression was localized within the deep crypt spaces where the symbiotic vibrios reside and along the surface of the epithelia [<xref rid="B51-antibiotics-03-00540" ref-type="bibr">51</xref>]. In the oyster <italic>Crassostrea gigas</italic>, a homologue of human BPI, <italic>Cg</italic>-BPI, is produced by various epithelial cell types including the intestine, gills, and mantle [<xref rid="B52-antibiotics-03-00540" ref-type="bibr">52</xref>]. In addition, the <italic>Cg</italic>-Defm defensin is expressed by the oyster mantle, the shell-forming secretory epithelium [<xref rid="B53-antibiotics-03-00540" ref-type="bibr">53</xref>]. Expression of <italic>Cg</italic>-BPI and <italic>Cg</italic>-Defm was constitutive in the epithelia of oysters infected with vibrios [<xref rid="B14-antibiotics-03-00540" ref-type="bibr">14</xref>]. Recently, a novel AMP rich in lysine residues was extracted from oyster gills. This AMP called <italic>Cg</italic>-Molluscidin is predicted to form a &#x003b1;-helix [<xref rid="B54-antibiotics-03-00540" ref-type="bibr">54</xref>]; its regulation in response to infection is still unknown. Moreover, as in fish, oyster epithelia accumulate histones displaying antimicrobial activity against vibrios [<xref rid="B55-antibiotics-03-00540" ref-type="bibr">55</xref>]. These antimicrobial histones are released in response to infection or injury by infiltrating hemocytes, the circulating immune cells of the oyster, by a mechanism reminiscent of neutrophil extracellular traps in vertebrates [<xref rid="B56-antibiotics-03-00540" ref-type="bibr">56</xref>].</p><table-wrap id="antibiotics-03-00540-t002" position="float"><object-id pub-id-type="pii">antibiotics-03-00540-t002_Table 2</object-id><label>Table 2</label><caption><p>Antimicrobial peptides (AMPs) expressed in epithelial tissues.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Species</th><th align="left" valign="top" rowspan="1" colspan="1">AMP family</th><th align="left" valign="top" rowspan="1" colspan="1">Examples</th><th align="left" valign="top" rowspan="1" colspan="1">Epithelial Tissues</th><th align="left" valign="top" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Human</td><td align="left" valign="top" rowspan="1" colspan="1">&#x003b1;-defensins</td><td align="left" valign="top" rowspan="1" colspan="1">HD-5, HD-6</td><td align="left" valign="top" rowspan="1" colspan="1">Small intestine, female genital tract</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="B37-antibiotics-03-00540" ref-type="bibr">37</xref>,<xref rid="B57-antibiotics-03-00540" ref-type="bibr">57</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
</td><td align="left" valign="top" rowspan="1" colspan="1">&#x003b2;-defensins</td><td align="left" valign="top" rowspan="1" colspan="1">hBD-1/-2/-3 </td><td align="left" valign="top" rowspan="1" colspan="1">Respiratory tract, large intestine, urogenital epithelium, oral cavity, skin</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="B58-antibiotics-03-00540" ref-type="bibr">58</xref>,<xref rid="B59-antibiotics-03-00540" ref-type="bibr">59</xref>,<xref rid="B60-antibiotics-03-00540" ref-type="bibr">60</xref>,<xref rid="B61-antibiotics-03-00540" ref-type="bibr">61</xref>,<xref rid="B62-antibiotics-03-00540" ref-type="bibr">62</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
</td><td align="left" valign="top" rowspan="1" colspan="1">Cathelicidins</td><td align="left" valign="top" rowspan="1" colspan="1">LL-37(hCAP-18)</td><td align="left" valign="top" rowspan="1" colspan="1">Skin, gastrointestinal tract, epididymis, lungs, oral cavity, ocular surface</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="B31-antibiotics-03-00540" ref-type="bibr">31</xref>,<xref rid="B63-antibiotics-03-00540" ref-type="bibr">63</xref>,<xref rid="B64-antibiotics-03-00540" ref-type="bibr">64</xref>], for review see [<xref rid="B65-antibiotics-03-00540" ref-type="bibr">65</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
</td><td align="left" valign="top" rowspan="1" colspan="1">Bactericidal-permeability increasing proteins</td><td align="left" valign="top" rowspan="1" colspan="1">BPI</td><td align="left" valign="top" rowspan="1" colspan="1">Esophagus, respiratory tract, large intestine</td><td align="left" valign="top" rowspan="1" colspan="1">For review see [<xref rid="B66-antibiotics-03-00540" ref-type="bibr">66</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
</td><td align="left" valign="top" rowspan="1" colspan="1">C-type lectins</td><td align="left" valign="top" rowspan="1" colspan="1">HIP/PAP</td><td align="left" valign="top" rowspan="1" colspan="1">Small intestine</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="B36-antibiotics-03-00540" ref-type="bibr">36</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Fish</td><td align="left" valign="top" rowspan="1" colspan="1">&#x003b2;-defensins</td><td align="left" valign="top" rowspan="1" colspan="1">omDB-1/-2/-3/-4</td><td align="left" valign="top" rowspan="1" colspan="1">Skin, gills, intestine</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="B45-antibiotics-03-00540" ref-type="bibr">45</xref>,<xref rid="B67-antibiotics-03-00540" ref-type="bibr">67</xref>] </td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
</td><td align="left" valign="top" rowspan="1" colspan="1">Cathelicidins</td><td align="left" valign="top" rowspan="1" colspan="1">rtCATH_1/-2A-2B, asCATH-1/-2 HFIAP-1/-2/-3</td><td align="left" valign="top" rowspan="1" colspan="1">Skin, gills, intestine</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="B47-antibiotics-03-00540" ref-type="bibr">47</xref>,<xref rid="B68-antibiotics-03-00540" ref-type="bibr">68</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
</td><td align="left" valign="top" rowspan="1" colspan="1">Liver-expressed antimicrobial peptides (LEAPs)</td><td align="left" valign="top" rowspan="1" colspan="1">Hepcidin (LEAP-1), LEAP-2<break/>Sal-1 Sal-2 </td><td align="left" valign="top" rowspan="1" colspan="1">Skin, intestine</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="B69-antibiotics-03-00540" ref-type="bibr">69</xref>], for review see [<xref rid="B44-antibiotics-03-00540" ref-type="bibr">44</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
</td><td align="left" valign="top" rowspan="1" colspan="1">&#x003b1;-helical peptides</td><td align="left" valign="top" rowspan="1" colspan="1">Pleurocidin,<break/>Piscidins<break/>Chrysophsins <break/>Moronecidin</td><td align="left" valign="top" rowspan="1" colspan="1">Skin, gills</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="B70-antibiotics-03-00540" ref-type="bibr">70</xref>,<xref rid="B71-antibiotics-03-00540" ref-type="bibr">71</xref>,<xref rid="B72-antibiotics-03-00540" ref-type="bibr">72</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
</td><td align="left" valign="top" rowspan="1" colspan="1">Bactericidal-permeability increasing proteins</td><td align="left" valign="top" rowspan="1" colspan="1">BPI</td><td align="left" valign="top" rowspan="1" colspan="1">Intestine, gills</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="B48-antibiotics-03-00540" ref-type="bibr">48</xref>,<xref rid="B49-antibiotics-03-00540" ref-type="bibr">49</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
</td><td align="left" valign="top" rowspan="1" colspan="1">Histone-derived AMPs</td><td align="left" valign="top" rowspan="1" colspan="1">Parasin-1<break/>Hipposin<break/>Oncorhyncin</td><td align="left" valign="top" rowspan="1" colspan="1">Skin mucus</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="B73-antibiotics-03-00540" ref-type="bibr">73</xref>,<xref rid="B74-antibiotics-03-00540" ref-type="bibr">74</xref>] <break/>[<xref rid="B44-antibiotics-03-00540" ref-type="bibr">44</xref>,<xref rid="B50-antibiotics-03-00540" ref-type="bibr">50</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Squid</td><td align="left" valign="top" rowspan="1" colspan="1">LPS-binding/ Bactericidal-permeability increasing proteins</td><td align="left" valign="top" rowspan="1" colspan="1"><italic>Es-</italic>LBP1</td><td align="left" valign="top" rowspan="1" colspan="1">Light organ</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="B51-antibiotics-03-00540" ref-type="bibr">51</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Oyster </td><td align="left" valign="top" rowspan="1" colspan="1">CS-&#x003b1;&#x003b2; defensins</td><td align="left" valign="top" rowspan="1" colspan="1"><italic>Cg-</italic>Defm</td><td align="left" valign="top" rowspan="1" colspan="1">Mantle tissue</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="B53-antibiotics-03-00540" ref-type="bibr">53</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
</td><td align="left" valign="top" rowspan="1" colspan="1">Bactericidal-permeability increasing proteins</td><td align="left" valign="top" rowspan="1" colspan="1"><italic>Cg-</italic>BPI</td><td align="left" valign="top" rowspan="1" colspan="1">Gills, mantle, labial palps, gastrointestinal tract</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="B52-antibiotics-03-00540" ref-type="bibr">52</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
</td><td align="left" valign="top" rowspan="1" colspan="1">Histone-derived AMPs</td><td align="left" valign="top" rowspan="1" colspan="1"><italic>cv</italic>H2B-1/-2/-3/-4</td><td align="left" valign="top" rowspan="1" colspan="1">Gills</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="B55-antibiotics-03-00540" ref-type="bibr">55</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Coral</td><td align="left" valign="top" rowspan="1" colspan="1">Cysteine Rich peptides</td><td align="left" valign="top" rowspan="1" colspan="1">Damicornin<break/>Mytimacin-like</td><td align="left" valign="top" rowspan="1" colspan="1">Oral ectoderm</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="B28-antibiotics-03-00540" ref-type="bibr">28</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
</td><td align="left" valign="top" rowspan="1" colspan="1">LPS-binding/ Bactericidal-permeability increasing proteins</td><td align="left" valign="top" rowspan="1" colspan="1">LBP&#x02013;BPI</td><td align="left" valign="top" rowspan="1" colspan="1">Oral ectoderm</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="B28-antibiotics-03-00540" ref-type="bibr">28</xref>]</td></tr></tbody></table></table-wrap></sec><sec><title>2.3. Vibrios Adapted to Intracellular Life in Phagocytes</title><p>Vibrios have traditionally been considered extracellular organisms. In recent years, however, vibrios (<italic>V. cholerae</italic> and <italic>V. mimicus</italic>) have been shown to also adopt intracellular stages in phagocytes from the environment, the amoebae [<xref rid="B75-antibiotics-03-00540" ref-type="bibr">75</xref>,<xref rid="B76-antibiotics-03-00540" ref-type="bibr">76</xref>,<xref rid="B77-antibiotics-03-00540" ref-type="bibr">77</xref>] (<xref ref-type="table" rid="antibiotics-03-00540-t003">Table 3</xref>). Similarly, live vibrios have been found inside professional phagocytes within the hosts they colonize. In vertebrates, <italic>V. cholerae</italic> can survive inside human macrophages; this intracellular stage is required for the T6SS-mediated secretion of factors causing actin cross-linking in host cells [<xref rid="B5-antibiotics-03-00540" ref-type="bibr">5</xref>]. In invertebrates, a <italic>V. splendidus</italic>-related strain referred to as <italic>V. tasmaniensis</italic> LGP32 can survive in hemocytes, the circulating immune cells of the oyster (<xref ref-type="table" rid="antibiotics-03-00540-t003">Table 3</xref>). Hemocyte invasion was accompanied by reduced production of reactive oxygen species and altered phagosome mutation [<xref rid="B6-antibiotics-03-00540" ref-type="bibr">6</xref>]. While vibrios pathogenic for fish can adopt intracellular stages in epithelial cells [<xref rid="B78-antibiotics-03-00540" ref-type="bibr">78</xref>,<xref rid="B79-antibiotics-03-00540" ref-type="bibr">79</xref>], to our knowledge they have not been reported to invade professional phagocytes.</p><table-wrap id="antibiotics-03-00540-t003" position="float"><object-id pub-id-type="pii">antibiotics-03-00540-t003_Table 3</object-id><label>Table 3</label><caption><p>Vibrios colonizing phagocytes.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Species or strain</th><th align="left" valign="top" rowspan="1" colspan="1">Host cells</th><th align="left" valign="top" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1"><italic>V. cholerae</italic> O1, O139</td><td align="left" valign="top" rowspan="1" colspan="1">amoebae</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="B75-antibiotics-03-00540" ref-type="bibr">75</xref>,<xref rid="B77-antibiotics-03-00540" ref-type="bibr">77</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic>V. cholerae</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">human macrophages</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="B5-antibiotics-03-00540" ref-type="bibr">5</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic>V. mimicus</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">amoebae</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="B76-antibiotics-03-00540" ref-type="bibr">76</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><italic>V. tasmaniensis</italic> LGP32</td><td align="left" valign="top" rowspan="1" colspan="1">oyster hemocytes</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="B6-antibiotics-03-00540" ref-type="bibr">6</xref>]</td></tr></tbody></table></table-wrap></sec><sec><title>2.4. AMPs of Phagocytes</title><p>Intracellular vibrios must face the potent chemical defenses of phagocytes, professional immune cells that circulate in the animal bloodstream and infiltrate infected tissues. Phagocyte defences include reactive oxygen species, which are particularly active during phagocytosis; hydrolytic enzymes including lysozyme; as well as AMPs, which are produced and stored by phagocytic cells (<xref ref-type="table" rid="antibiotics-03-00540-t004">Table 4</xref>). </p><p>Human phagocytes (neutrophils and macrophages) are indeed known to express a broad diversity of AMPs. Neutrophils express &#x003b1;-defensins, stored in azurophil granules that fuse with the phagolysosome to kill internalized bacteria, and the LL-37 cathelicidin, stored in secretory granules which release their content extracellularly. &#x003b1;-defensin expression is constitutive and their release is regulated by diverse microbial signals. In neutrophil phagolysosomes, the concentration of defensins has been estimated at ~10 mg/mL [<xref rid="B80-antibiotics-03-00540" ref-type="bibr">80</xref>]. In addition, human neutrophils express the BPI antimicrobial protein [<xref rid="B30-antibiotics-03-00540" ref-type="bibr">30</xref>]. In human macrophages, where <italic>V. cholerae</italic> is able to survive, AMPs such as LL-37, hepcidin and human &#x003b2;-defensin 1 and 2 can control intracellular pathogens [<xref rid="B81-antibiotics-03-00540" ref-type="bibr">81</xref>,<xref rid="B82-antibiotics-03-00540" ref-type="bibr">82</xref>]. Indeed, the crucial role of LL-37 in intracellular killing of mycobacteria has been extensively documented [<xref rid="B83-antibiotics-03-00540" ref-type="bibr">83</xref>,<xref rid="B84-antibiotics-03-00540" ref-type="bibr">84</xref>]. </p><p>In fish, less information is available on AMPs expressed by phagocytes. AMPs of granulocytes include the &#x003b1;-helical peptide piscidin [<xref rid="B85-antibiotics-03-00540" ref-type="bibr">85</xref>] and hepcidin in the seabream [<xref rid="B86-antibiotics-03-00540" ref-type="bibr">86</xref>]. The BPI/LBP protein is constitutively expressed in head kidney leukocytes from Atlantic cod [<xref rid="B49-antibiotics-03-00540" ref-type="bibr">49</xref>]. However, attention must be paid to the potential infiltration of phagocytes in tissues when AMPs expression is analyzed. Therefore, further studies are needed to determine whether the AMP expression in fish is restricted to a specific cell type or tissue. It is also not known whether fish phagocytes serve as a niche for any given <italic>Vibrio</italic> species.</p><p>Hemocytes of invertebrates also produce a large array of AMPs. Upon infection, oyster hemocytes massively migrate to infected tissues, bringing their antimicrobial content to the site of infection, and actively phagocytose bacteria. In oyster hemocytes, where the <italic>V. tasmaniensis</italic> strain LGP32 was found to survive, AMPs include defensins, big-defensins, proline-rich peptides, as well as a BPI antimicrobial protein (for review see [<xref rid="B1-antibiotics-03-00540" ref-type="bibr">1</xref>]). BPI is stored in large cytoplasmic granules while the intracellular localization of the other AMPs is not yet known. Expression of BPI and big-defensin 1 and 2 is induced in hemocytes of infected oysters, whereas defensin expression is not regulated by the infection [<xref rid="B14-antibiotics-03-00540" ref-type="bibr">14</xref>,<xref rid="B87-antibiotics-03-00540" ref-type="bibr">87</xref>].</p><p>Similar to phagocytes from metazoans, amoebae, which can host diverse <italic>Vibrio</italic> species, produce pore-forming polypeptides such as the well-known amoebapores. These peptides are stored in cytoplasmic granules and can rapidly perforate human and bacterial cells. Amoebapores combat the growth of phagocytosed bacteria by permeabilizing their membranes inside the digestive vacuoles [<xref rid="B88-antibiotics-03-00540" ref-type="bibr">88</xref>].</p><table-wrap id="antibiotics-03-00540-t004" position="float"><object-id pub-id-type="pii">antibiotics-03-00540-t004_Table 4</object-id><label>Table 4</label><caption><p>AMPs expressed in phagocytes.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Species</th><th align="left" valign="top" rowspan="1" colspan="1">AMP</th><th align="left" valign="top" rowspan="1" colspan="1">Examples </th><th align="left" valign="top" rowspan="1" colspan="1">Phagocytes</th><th align="left" valign="top" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Human</td><td align="left" valign="top" rowspan="1" colspan="1">&#x003b1;-defensins</td><td align="left" valign="top" rowspan="1" colspan="1">HNP-1/-2/-3/-4</td><td align="left" valign="top" rowspan="1" colspan="1">Neutrophils</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="B80-antibiotics-03-00540" ref-type="bibr">80</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
</td><td align="left" valign="top" rowspan="1" colspan="1">&#x003b2;-defensins</td><td align="left" valign="top" rowspan="1" colspan="1">hBD-1/-2</td><td align="left" valign="top" rowspan="1" colspan="1">Macrophages, Dendritic cells</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="B81-antibiotics-03-00540" ref-type="bibr">81</xref>,<xref rid="B82-antibiotics-03-00540" ref-type="bibr">82</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
</td><td align="left" valign="top" rowspan="1" colspan="1">Cathelicidins </td><td align="left" valign="top" rowspan="1" colspan="1">LL-37</td><td align="left" valign="top" rowspan="1" colspan="1">Neutrophils</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="B89-antibiotics-03-00540" ref-type="bibr">89</xref>,<xref rid="B90-antibiotics-03-00540" ref-type="bibr">90</xref>] </td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
</td><td align="left" valign="top" rowspan="1" colspan="1">Liver-expressed antimicrobial peptides (LEAPs)</td><td align="left" valign="top" rowspan="1" colspan="1">Hepcidin</td><td align="left" valign="top" rowspan="1" colspan="1">Granulocytes Macrophages</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="B91-antibiotics-03-00540" ref-type="bibr">91</xref>,<xref rid="B92-antibiotics-03-00540" ref-type="bibr">92</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
</td><td align="left" valign="top" rowspan="1" colspan="1">Bactericidal-permeability <break/>increasing proteins</td><td align="left" valign="top" rowspan="1" colspan="1">BPI</td><td align="left" valign="top" rowspan="1" colspan="1">Neutrophils, (Eosinophils/to a lesser extent)</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="B30-antibiotics-03-00540" ref-type="bibr">30</xref>,<xref rid="B93-antibiotics-03-00540" ref-type="bibr">93</xref>,<xref rid="B94-antibiotics-03-00540" ref-type="bibr">94</xref>]<break/>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Fish</td><td align="left" valign="top" rowspan="1" colspan="1">&#x003b1;-helical peptides</td><td align="left" valign="top" rowspan="1" colspan="1">Piscidins</td><td align="left" valign="top" rowspan="1" colspan="1">Granulocytes</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="B85-antibiotics-03-00540" ref-type="bibr">85</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
</td><td align="left" valign="top" rowspan="1" colspan="1">LPS-Binding/Bactericidal-permeability increasing proteins</td><td align="left" valign="top" rowspan="1" colspan="1">LBP/BPI</td><td align="left" valign="top" rowspan="1" colspan="1">Head&#x02013;kidney leukocytes</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="B49-antibiotics-03-00540" ref-type="bibr">49</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Oyster</td><td align="left" valign="top" rowspan="1" colspan="1">CS-&#x003b1;&#x003b2; defensins</td><td align="left" valign="top" rowspan="1" colspan="1"><italic>Cg-</italic>Defh-1/h2</td><td align="left" valign="top" rowspan="1" colspan="1">Hemocytes</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="B1-antibiotics-03-00540" ref-type="bibr">1</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
</td><td align="left" valign="top" rowspan="1" colspan="1">Big-defensins</td><td align="left" valign="top" rowspan="1" colspan="1"><italic>Cg-</italic>big-defensin-1/-2/-3</td><td align="left" valign="top" rowspan="1" colspan="1">Hemocytes</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="B87-antibiotics-03-00540" ref-type="bibr">87</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
</td><td align="left" valign="top" rowspan="1" colspan="1">Proline-rich peptides</td><td align="left" valign="top" rowspan="1" colspan="1"><italic>Cg-</italic>Prp</td><td align="left" valign="top" rowspan="1" colspan="1">Hemocytes</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="B14-antibiotics-03-00540" ref-type="bibr">14</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
</td><td align="left" valign="top" rowspan="1" colspan="1">Bactericidal-permeability increasing protein</td><td align="left" valign="top" rowspan="1" colspan="1"><italic>Cg-</italic>BPI</td><td align="left" valign="top" rowspan="1" colspan="1">Hemocytes</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="B14-antibiotics-03-00540" ref-type="bibr">14</xref>,<xref rid="B52-antibiotics-03-00540" ref-type="bibr">52</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
</td><td align="left" valign="top" rowspan="1" colspan="1">Histone-derived AMPs</td><td align="left" valign="top" rowspan="1" colspan="1">H1- and H5-like histones</td><td align="left" valign="top" rowspan="1" colspan="1">Hemocytes</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="B56-antibiotics-03-00540" ref-type="bibr">56</xref>]</td></tr></tbody></table></table-wrap></sec></sec><sec><title>3. Known Mechanisms of Resistance/Evasion to AMPs in Vibrios</title><sec><title>3.1. Outer Membrane Remodeling</title><p>As electrostatic interactions often play a crucial role in the initial interaction of cationic AMPs with bacterial membranes, both Gram-negative and Gram-positive bacteria have evolved strategies to neutralize the net negative charge of cell surface molecules with amine-containing substitutions. Thus, D-alanylation of teichoic acids, which are major components of the Gram-positive cell wall, confers AMP-resistance in a variety of Gram-positive bacteria including <italic>Staphylococcus aureus</italic> and <italic>Bacillus cereus</italic> [<xref rid="B95-antibiotics-03-00540" ref-type="bibr">95</xref>,<xref rid="B96-antibiotics-03-00540" ref-type="bibr">96</xref>]. More generally, aminoacylation of bacterial cell surface phosphatidylglycerols with L-lysine, L-alanine, or D-alanine confers resistance to cationic AMPs in both Gram-positive and Gram-negative bacteria [<xref rid="B97-antibiotics-03-00540" ref-type="bibr">97</xref>].</p><p>LPS, the major constituent in the Gram-negative outer membrane, is composed of three regions: the anionic Lipid A membrane anchor, the core oligosaccharide and the O-antigen polysaccharide [<xref rid="B98-antibiotics-03-00540" ref-type="bibr">98</xref>]. Hankins <italic>et al.</italic> have shown that <italic>V. cholerae</italic> O1 and O139 share identical asymmetrical hexa-acylated Lipid A structures [<xref rid="B99-antibiotics-03-00540" ref-type="bibr">99</xref>] composed of a &#x003b2; 1'-6 linked glucosamine disaccharide with unmodified 1- and 4'-phosphate groups, which is acylated at the 2-, 3-, 2'- and 3'-positions. Myristate (C14:0) and 3-hydroxylaurate (3-OH C12:0) are ester-linked to the hydroxyl groups on the 2'- and 3'-linked fatty acyl chains (<xref ref-type="fig" rid="antibiotics-03-00540-f001">Figure 1</xref>). As in <italic>V. cholerae</italic>, the presence of a hydroxylated secondary acyl chain has been reported in the Lipid A structure of <italic>V. fischeri</italic> [<xref rid="B100-antibiotics-03-00540" ref-type="bibr">100</xref>].</p><fig id="antibiotics-03-00540-f001" position="float"><label>Figure 1</label><caption><p>Structure of modified lipid A from <italic>V. cholerae</italic> O1 El Tor. The structure of <italic>V. cholerae</italic> lipid A was established by Hankins <italic>et al.</italic> (2011) [<xref rid="B99-antibiotics-03-00540" ref-type="bibr">99</xref>]. It is composed of a &#x003b2; 1&#x02032;-6 linked glucosamine disaccharide with unmodified 1- and 4&#x02032;-phosphate groups, which is acylated at the 2-, 3-, 2&#x02032;- and 3&#x02032;-positions. Myristate (C14:0) and 3-hydroxylaurate (3-OH C12:0) are ester-linked to the hydroxyl groups on the 2&#x02032;- and 3&#x02032;-linked fatty acyl chains. The 3-hydroxylaurate secondary acyl chain transferred by the LpxN acyltransferase is required for AMP resistance. Similarly, the di-Glycine residues transferred by the AlmG to the hexa-acylated lipid A of <italic>V. cholerae</italic> O1 El Tor strains are crucial for AMP-resistance [<xref rid="B101-antibiotics-03-00540" ref-type="bibr">101</xref>].</p></caption><graphic xlink:href="antibiotics-03-00540-g001"/></fig><p>Polymyxin B (PmB) has been extensively used to study the molecular basis of bacterial resistance to cationic AMPs in Gram-negative bacteria. Indeed, this peptide produced by the Gram-positive <italic>Paenibacillus polymyxa</italic> disrupts the cell envelope of Gram-negative bacteria by associating with the anionic LPS as well as with acidic glycerophospholipids [<xref rid="B102-antibiotics-03-00540" ref-type="bibr">102</xref>]. To resist to AMPs, Gram-negative bacteria can neutralize their cell membrane by transferring phosphoethanolamine or aminoarabinose to phosphate groups on the lipid A domain of LPS [<xref rid="B103-antibiotics-03-00540" ref-type="bibr">103</xref>].</p><p>In <italic>V. cholerae</italic>, the secondary acyltransferase VC0212 (LpxN or MsbB), which transfers a 3-hydroxylaurate group to penta-acylated Lipid A, contributes to the resistance of an El Tor strain to AMPs including PmB and LL-37 [<xref rid="B99-antibiotics-03-00540" ref-type="bibr">99</xref>,<xref rid="B104-antibiotics-03-00540" ref-type="bibr">104</xref>]. Thus, the higher susceptibility of the <italic>vc0212</italic> mutant displaying incomplete Lipid A might be due to the greater permeability of its bacterial membrane. However, recent data by Hankins <italic>et al</italic>. demonstrated that the presence of a 3-hydroxyl group on the secondary acyl chain provides a site for esterification of glycine residues in a unique strategy necessary for resistance to PmB in <italic>V. cholerae</italic> [<xref rid="B101-antibiotics-03-00540" ref-type="bibr">101</xref>] (<xref ref-type="fig" rid="antibiotics-03-00540-f001">Figure 1</xref>). </p><p>Three <italic>V. cholerae</italic> proteins, VC1577 (AlmG), VC1578 (AlmF), and VC1579 (AlmE) sharing sequence homology with the machinery involved in D-alanylation of teichoic acids in Gram-positive bacteria are essential for Lipid A modification with glycine and diglycine residues through aminoacyl esterification (<xref ref-type="fig" rid="antibiotics-03-00540-f001">Figure 1</xref>). Interestingly, sequence alignments comparing the classical (susceptible to PmB) and the El Tor (resistant to PmB) biotypes of <italic>V. cholerae</italic> revealed that the classical strain O395 has a nonsense mutation, resulting in a truncated AlmF carrier protein lacking the conserved serine [<xref rid="B101-antibiotics-03-00540" ref-type="bibr">101</xref>]. The authors discovered that classical strains lack glycine-modified Lipid A. Upon <italic>alm</italic> mutation, the minimum inhibitory concentration (MIC) of PmB against El Tor strains dropped dramatically (~100 times) from 96&#x02013;128 &#x003bc;g/mL to 0.5&#x02013;1.0 &#x003bc;g/mL, showing that glycine modification of Lipid A is an essential mechanism of AMP resistance in <italic>V. cholerae</italic>. This study provides a well-defined mechanism for the different PmB-resistant phenotypes observed in <italic>V. cholerae</italic> classical and El Tor biotypes. Why classical strains appear to have lost carrier protein functionality and thus AMP resistance is a puzzling evolutionary question.</p><p>To date, it is unknown whether modifications of <italic>Vibrio</italic> LPS are induced upon exposure to sublethal concentrations of cationic AMPs, as shown in other bacterial species like Salmonella Typhimurium, which regulate their LPS structure, contributing to resistance to cationic AMP [<xref rid="B105-antibiotics-03-00540" ref-type="bibr">105</xref>]. Changes in <italic>Salmonella</italic> LPS structure, regulated by the two-component system PhoPQ, include reducing average O-antigen chain-length, acylating, deacylating, and hydroxylating lipid A, derivatizing lipid A and LPS core phosphates with cationic groups (for recent review see [<xref rid="B106-antibiotics-03-00540" ref-type="bibr">106</xref>]). Homologues of PhoPQ are found in <italic>Vibrio</italic> species, however, the potential role of PhoPQ in resistance to AMPs has not been described to date.</p></sec><sec><title>3.2. Induction of the Envelope Stress Response</title><p>As discussed above, many AMPs create damage to bacterial membranes as part of their mechanism of action. Sensing external stress is therefore crucial to combating membrane injury before the damage becomes irreversible. One of the strategies by which bacteria respond to outer membrane stress and modulate gene expression is via the alternate &#x003c3;E factor, encoded by the <italic>rpoE</italic> gene. Under non-stress conditions, &#x003c3;E is inactivated by its cognate anti-sigma factor localized to the inner membrane. When activated by envelope stress, <italic>i.e.</italic>, misfolding of outer membrane proteins, &#x003c3;E promotes the expression of factors that help preserve and/or restore cell envelope integrity. Certain outer membrane proteins can serve as upstream signal sensors to modulate the activity of &#x003c3;E [<xref rid="B107-antibiotics-03-00540" ref-type="bibr">107</xref>]. In <italic>V. cholerae,</italic> the major outer membrane OmpU is a key determinant of &#x003c3;E production [<xref rid="B108-antibiotics-03-00540" ref-type="bibr">108</xref>]. Such dependence on a single factor contrasts with the regulation of &#x003c3;E in <italic>E. coli</italic>, in which numerous factors contribute to its activation and none is dominant. </p><p>In <italic>V. cholerae</italic>, &#x003c3;E plays a role in outer membrane stress response and resistance to AMPs. Thus, deficiency of &#x003c3;E confers to <italic>V. cholerae</italic> greater sensitivity to the antimicrobial peptide P2, a synthetic derivative of human BPI. Consistent with the <italic>ompU</italic>-dependent activation of &#x003c3;E, lack of OmpU in <italic>V. cholerae</italic> also conferred a greater sensitivity to AMPs [<xref rid="B109-antibiotics-03-00540" ref-type="bibr">109</xref>,<xref rid="B110-antibiotics-03-00540" ref-type="bibr">110</xref>]. Similar results were obtained for the oyster pathogen <italic>V. tasmaniensis</italic> LGP32 in which OmpU contributed to resistance to the oyster antimicrobials <italic>Cg</italic>-Defm and <italic>Cg-</italic>BPI [<xref rid="B111-antibiotics-03-00540" ref-type="bibr">111</xref>]. However, in both <italic>V. cholerae</italic> and <italic>V. tasmaniensis</italic>, OmpU-mediated resistance was much lower than that conferred by Lipid A remodeling [<xref rid="B101-antibiotics-03-00540" ref-type="bibr">101</xref>]. Moreover, in <italic>V. tasmaniensis</italic> LGP32, the major negative effect of the <italic>ompU</italic> deletion on pathogenicity was attributed to impaired capacity to invade the oyster immune cells rather than lower resistance to oyster AMPs [<xref rid="B6-antibiotics-03-00540" ref-type="bibr">6</xref>].</p></sec><sec><title>3.3. AMP Titration by Outer Membrane Vesicles</title><p>One &#x003c3;E-dependent mechanism whose role in AMP resistance has been less studied is outer membrane vesicle release. OMVs form the insoluble fraction of Gram-negative bacteria extracellular products; they are extruded from the bacterial cell surface and entrap some of the underlying periplasmic contents [<xref rid="B112-antibiotics-03-00540" ref-type="bibr">112</xref>,<xref rid="B113-antibiotics-03-00540" ref-type="bibr">113</xref>]. OMVs are key players in the interaction between Gram-negative bacteria and both the prokaryotic and eukaryotic cells from their environment [<xref rid="B114-antibiotics-03-00540" ref-type="bibr">114</xref>]. Whereas it is now well established that <italic>Vibrio</italic> spp. constitutively release OMVs during cell growth [<xref rid="B115-antibiotics-03-00540" ref-type="bibr">115</xref>,<xref rid="B116-antibiotics-03-00540" ref-type="bibr">116</xref>,<xref rid="B117-antibiotics-03-00540" ref-type="bibr">117</xref>], only recent studies in <italic>E. coli</italic> [<xref rid="B118-antibiotics-03-00540" ref-type="bibr">118</xref>] and <italic>Vibrio</italic> spp. [<xref rid="B119-antibiotics-03-00540" ref-type="bibr">119</xref>,<xref rid="B120-antibiotics-03-00540" ref-type="bibr">120</xref>] have shown that the release of OMVs protects bacteria against membrane-active AMPs.</p><p>In <italic>V. cholerae</italic>, earlier work demonstrated that under envelope stress conditions, the small regulatory RNA VrrA is expressed in a &#x003c3;E-dependent manner to down-regulate OmpA, which in turn reduces envelope stress by promoting OMV release [<xref rid="B121-antibiotics-03-00540" ref-type="bibr">121</xref>]. More recently, we found that physiologically relevant amounts of OMVs produced in the presence of a sub-lethal concentration of PmB provide protection against human cathelicidin LL-37, increasing the MIC of LL-37 by four-fold. This cross-protection has been attributed to the presence of the biofilm-associated extracellular matrix protein Bap1, which is associated with OMVs in larger amounts when bacteria are grown in the presence of PmB. The Bap1 protein can therefore trap LL-37, leading to increased resistance of <italic>V. cholerae</italic> towards LL-37 [<xref rid="B119-antibiotics-03-00540" ref-type="bibr">119</xref>].</p><p>In <italic>V. tasmaniensis</italic> LGP32, OMVs provide significant and dose-dependent protection against AMPs [<xref rid="B120-antibiotics-03-00540" ref-type="bibr">120</xref>]. Indeed, OMVs increased the MIC of PmB from 2&#x02013;16-fold at OMV concentrations ranging from 6.25&#x02013;50 &#x003bc;g/mL. This protective effect was attributed to the binding of PmB to OMVs; no proteolytic degradation of the peptide was observed. Interestingly, the addition of oyster plasma to the culture medium strongly stimulated the release of OMVs by <italic>V. tasmaniensis</italic> LGP32. This indicates that as in <italic>E. coli,</italic> in which sub-lethal concentrations of AMPs promote OMV release [<xref rid="B118-antibiotics-03-00540" ref-type="bibr">118</xref>], OMV release in vibrios is likely up-regulated by membrane-active agents in oyster plasma. Consistent with this hypothesis, LGP32 lacking the major outer membrane protein OmpU, which controls envelope stress signaling in vibrios [<xref rid="B108-antibiotics-03-00540" ref-type="bibr">108</xref>], showed a hypervesiculation phenotype (<xref ref-type="fig" rid="antibiotics-03-00540-f002">Figure 2</xref>A).</p><p>Altogether, these recent studies indicate that OMVs are a potent strategy used by vibrios to trap membrane-active AMPs such as PmB or LL-37, forming a protective shield that prevents interaction with the membranes of the bacterial cell (<xref ref-type="fig" rid="antibiotics-03-00540-f002">Figure 2</xref>B). Although OMVs released by vibrios can contain specific proteases like the recently identified vesicular serine protease Vsp (VS_II0815) of <italic>V. tasmaniensis</italic> LGP32, there is to date no evidence of AMP degradation by OMV-encapsulated content [<xref rid="B119-antibiotics-03-00540" ref-type="bibr">119</xref>,<xref rid="B120-antibiotics-03-00540" ref-type="bibr">120</xref>].</p><fig id="antibiotics-03-00540-f002" position="float"><label>Figure 2</label><caption><p>Model for AMP-titration by outer membrane vesicles (OMVs) in <italic>V. cholerae</italic> and <italic>V. tasmaniensis</italic>. (<bold>A</bold>) OMVs released in the extracellular medium by the hypervesiculating &#x00394;<italic>ompU</italic> mutant of <italic>V. tasmaniensis</italic> strain LGP32. Logarithmic phase cultures were negatively stained and observed by transmission electron microscopy as described in [<xref rid="B120-antibiotics-03-00540" ref-type="bibr">120</xref>]; (<bold>B)</bold> The role of OMVs in the protection against AMPs has been recently described in two species of vibrios. In <italic>V. cholerae</italic>, OMVs cross-protect against the human cathelicidin LL-37 when bacteria are exposed to sublethal concentrations of PmB. Those OMVs are associated with Bap1 protein which serves as a ligand for LL-37. The association of Bap1 to OMVs is mediated by the outer membrane protein, OmpT [<xref rid="B119-antibiotics-03-00540" ref-type="bibr">119</xref>]. In <italic>V. tasmaniensis</italic>, OMVs produced in the absence of AMPs are sufficient to titrate PmB and confer a potent dose-dependent protection against PmB. Although the molecular basis of PmB binding to <italic>V. tasmaniensis</italic> OMVs remain unknown, it is speculated that titration may occur by PmB insertion in the OMV membranes. The release of OMVs was shown to be strongly enhanced by the contact of <italic>V. tasmaniensis</italic> with oyster plasma [<xref rid="B120-antibiotics-03-00540" ref-type="bibr">120</xref>]. In both species, OMV release is thought to create a protective membranous shield that prevents the interaction of membrane-active AMPs with the bacterial membranes.</p></caption><graphic xlink:href="antibiotics-03-00540-g002"/></fig></sec><sec><title>3.4. Efflux of AMPs</title><p>The involvement of efflux pumps in antimicrobial resistance, especially in antibiotic resistance, is well established in Gram-negative bacteria [<xref rid="B122-antibiotics-03-00540" ref-type="bibr">122</xref>,<xref rid="B123-antibiotics-03-00540" ref-type="bibr">123</xref>]. There are five different active efflux systems described in bacteria: the ATP-binding cassette superfamily (ABC), the small multidrug resistance family (SMR), the multi antimicrobial extrusion protein family (MATE), the major facilitator superfamily (MFS), and the resistance-nodulation-cell division superfamily (RND) [<xref rid="B124-antibiotics-03-00540" ref-type="bibr">124</xref>]. In terms of antimicrobial resistance, the RND family efflux pumps are particularly important in Gram-negative bacteria. RND efflux systems are composed of an outer membrane protein homologous to the transmembrane &#x003b2;-barrel TolC protein of <italic>E. coli</italic>, a periplasmic membrane fusion protein (MFP), and an integral cytoplasmic membrane pump protein belonging to the RND superfamily of transporters (for review see [<xref rid="B125-antibiotics-03-00540" ref-type="bibr">125</xref>]). These three components function to form a channel to extrude substrates from the cell envelope into the environment. The <italic>V. cholerae</italic> VexAB-TolC [<xref rid="B126-antibiotics-03-00540" ref-type="bibr">126</xref>,<xref rid="B127-antibiotics-03-00540" ref-type="bibr">127</xref>], the <italic>E. coli</italic> and <italic>Salmonella enterica</italic> AcrAB-TolC [<xref rid="B128-antibiotics-03-00540" ref-type="bibr">128</xref>,<xref rid="B129-antibiotics-03-00540" ref-type="bibr">129</xref>], and the <italic>Pseudomonas aeruginosa</italic> MexAB-OprM systems [<xref rid="B130-antibiotics-03-00540" ref-type="bibr">130</xref>] function as RND efflux systems. </p><p>In <italic>V. cholerae</italic>, six RND efflux pumps have been described: VexAB, VexCD, VexEF, VexGH, VexIJK, and VexLM [<xref rid="B131-antibiotics-03-00540" ref-type="bibr">131</xref>]. Among them, four are required for antimicrobial resistance <italic>in vitro.</italic> VexAB is the main efflux pump involved in the resistance to antimicrobials including bile acids, detergents, antibiotics, and PmB. The MIC of PmB dropped by four-fold (from 110&#x02013;27 &#x003bc;g/mL) after <italic>vexB</italic> mutation in <italic>V. cholerae</italic> [<xref rid="B127-antibiotics-03-00540" ref-type="bibr">127</xref>,<xref rid="B132-antibiotics-03-00540" ref-type="bibr">132</xref>]. Moreover, the MIC of PmB against the <italic>vexB</italic> mutant was comparable with the MIC against the RND-null strain, indicating that only VexAB is involved in resistance to PmB [<xref rid="B127-antibiotics-03-00540" ref-type="bibr">127</xref>]. Besides VexAB, VexGH also contributes to antibiotic (novobiocin and ampicillin) and detergent resistance but to a lesser extent than VexAB. Indeed, a decrease in the MIC can be observed only for a <italic>vexBH</italic> double mutant but not for the <italic>vexH</italic> single mutant, compared to the wild-type and <italic>vexB</italic> single mutant strains [<xref rid="B133-antibiotics-03-00540" ref-type="bibr">133</xref>]. Finally, VexCD and VexIJK appeared to efflux bile acids and detergents, respectively [<xref rid="B127-antibiotics-03-00540" ref-type="bibr">127</xref>,<xref rid="B132-antibiotics-03-00540" ref-type="bibr">132</xref>]. VexEF and VexLM do not participate in antimicrobial resistance, but are required for the full virulence of <italic>V. cholerae</italic> by influencing the production of the major effectors of virulence, <italic>i.e.</italic>, cholera toxin and the toxin co-regulated pilus [<xref rid="B133-antibiotics-03-00540" ref-type="bibr">133</xref>]. In <italic>V. parahaemolyticus</italic>, proteomic identification of membrane proteins up-regulated in strains that artificially evolved resistant to AMPs, (including the fish AMP pleurocidin) led to the identification of TolC [<xref rid="B134-antibiotics-03-00540" ref-type="bibr">134</xref>]. Unfortunately, its role in AMP resistance in <italic>V. parahaemolyticus</italic> has not been investigated further<italic>.</italic></p><p>In addition to efflux pumps, a K<sup>+</sup> pump encoded by the <italic>trkA</italic> gene has been described in <italic>V. vulnificus</italic>, and its role in AMP and serum resistance investigated [<xref rid="B135-antibiotics-03-00540" ref-type="bibr">135</xref>]. The <italic>trkA</italic> gene product, TrkA, is a cytoplasmic protein bound to the inner side of the cytoplasmic membrane [<xref rid="B136-antibiotics-03-00540" ref-type="bibr">136</xref>]. In <italic>V. vulnificus</italic>, the <italic>trkA</italic> mutant exhibited attenuated growth at intermediate potassium concentrations and was more sensitive to human serum protamine and PmB than was the wild type. Indeed, in contrast to the wild-type strain, the <italic>trkA</italic> mutant lysed in the presence of 10&#x02013;20 &#x003bc;g/mL of protamine, and 5&#x02013;15 &#x003bc;g/mL of PmB [<xref rid="B135-antibiotics-03-00540" ref-type="bibr">135</xref>]. Moreover, TrkA was found to be important for <italic>V. vulnificus</italic> virulence in mice [<xref rid="B135-antibiotics-03-00540" ref-type="bibr">135</xref>].</p></sec><sec><title>3.5. Suppression of AMP Expression</title><p>Pathogenic bacteria have developed multiple modalities to combat the antimicrobial response of their hosts. In addition to the structural modifications reviewed above, which increase their resistance to AMPs, they also use transcriptional repression as a strategy to evade the host immune system. Thus, the down-regulation of AMPs can be considered a general mechanism to facilitate invasion of pathogenic bacteria, including vibrios. </p><p>In humans, where the interaction of <italic>V. cholerae</italic> with intestinal epithelial cells is a critical step in the disease process, down-regulation of the cathelicidin LL-37, but not of the defensin HBD-1 has been reported in the presence of enteric pathogens including <italic>V. cholerae</italic> O139 [<xref rid="B137-antibiotics-03-00540" ref-type="bibr">137</xref>]. The authors showed that cholera toxin (CT) was the predominant molecule associated with the regulation of AMPs by <italic>V. cholerae</italic> spp. <italic>in vitro</italic> and <italic>in vivo</italic> using intestinal epithelial cells and ileal loop experiments, respectively [<xref rid="B137-antibiotics-03-00540" ref-type="bibr">137</xref>]. Moreover, multiple signaling pathways activated downstream of intracellular accumulation of cAMP contribute to the CT-mediated suppression of LL-37 in intestinal epithelial cells [<xref rid="B137-antibiotics-03-00540" ref-type="bibr">137</xref>]. However, a more recent study on small intestine biopsies of patients with <italic>V. cholerae</italic> O1 infections did not show transcriptional repression of AMP genes in the small intestine [<xref rid="B138-antibiotics-03-00540" ref-type="bibr">138</xref>], a discrepancy that might be explained by differences in transcriptional regulation <italic>in vivo</italic> and <italic>in vitro</italic>. <italic>In vivo</italic>, the expression of hBD-1, -3 and -4 did not vary with the infection, whereas hBD-2 mRNA levels were significantly higher at the acute stage of cholera than at the convalescent stage and in healthy controls. Paneth cell-derived HD-5 and HD-6, which were all expressed at high levels in controls, were not affected by the infections. While no transcriptional repression could be observed, the authors reported that hBD-2, HD-5 and LL-37 peptides are normally present in the small intestine epithelium and amounts decrease at the acute stage of watery diarrhea. Lower amounts of HD-5 could result from degranulation of the Paneth cells in response to infection. The processes regulating hBD-2 and LL-7 levels remain to be characterized.</p><p>In invertebrate hosts, similar downregulation of antimicrobial peptides and proteins has been observed during vibrioses. For instance, the coral pathogen, <italic>V. coralliilyticus</italic>, represses the expression of the damicornin, an AMP expressed by the scleractinian coral <italic>Pocillopora damicornis</italic> [<xref rid="B28-antibiotics-03-00540" ref-type="bibr">28</xref>]. Indeed, damicornin transcripts increased during the first 6 days after infection with <italic>V. coralliilyticus</italic>, directly followed by a dramatic decrease from days 9&#x02013;18. Conversely, no transcriptional change was observed when <italic>P. damicornis</italic> was exposed to a nonvirulent state of <italic>V. coralliilyticus</italic> [<xref rid="B28-antibiotics-03-00540" ref-type="bibr">28</xref>]. Since <italic>V. coralliilyticus</italic> enters into the ectodermal coral tissue within 6 days, the authors suggested that a first phase of infection, involving bacterial recognition by host cells, triggers a nonspecific inflammatory response that activates damicornin gene transcription. In a second phase, following bacterial invasion, the pathogen suppresses damicornin transcription. This study represents the first characterization of the immunosuppression of AMP expression in an invertebrate-vibrio model of pathogenesis. More recently, using a global RNAseq approach, the same authors showed that not only damicornin, but also a mytimacin-like and a LBP-BPI gene displayed decreased expression during a successful <italic>V. coralliilyticus</italic> infection [<xref rid="B139-antibiotics-03-00540" ref-type="bibr">139</xref>].</p><p>In mollusks, repression of AMP transcription has not been demonstrated <italic>per se</italic>. Indeed, upon infection of oysters with the pathogen <italic>V. tasmaniensis</italic> LGP32, major hemocyte movements occur which, by bringing AMP-producing hemocytes to infected tissues, create an apparent depletion in <italic>Cg</italic>-Defm and <italic>Cg</italic>-BPI transcripts in the circulating hemocytes. However, those transcripts accumulate at the same time in the hemocyte-infiltrated tissues [<xref rid="B14-antibiotics-03-00540" ref-type="bibr">14</xref>]. A similar apparent repression of defensin expression was observed in the circulating hemocytes of a heterologous host, the mussel, infected with <italic>V. tasmaniensis</italic> LGP32 [<xref rid="B140-antibiotics-03-00540" ref-type="bibr">140</xref>]. However, to date, the only AMP whose transcription is likely down-regulated by LGP32 is a proline-rich peptide from the oyster which acts by synergism with the other AMPs [<xref rid="B14-antibiotics-03-00540" ref-type="bibr">14</xref>]. </p></sec></sec><sec><title>4. Conclusions</title><p>While vibrios have evolved the capacity to colonize immune tissues such as epithelia and phagocytes, only recent studies have started to investigate the mechanism by which they can survive the high AMP concentrations they encounter. Among their potent mechanisms of resistance to AMPs, vibrios use novel mechanisms of membrane remodeling. In particular, some highly resistant strains substitute their hexaacylated Lipid A with a diglycine residue to reduce the negative charge of their surface thereby lowering the electrostatic interaction with cationic AMPs. As a response to envelope stress, which can be induced by membrane-active agents including AMPs, vibrios release outer membrane vesicles to create a protective membranous shield that traps AMPs and prevents interaction of the peptides with their own membranes. Finally, once AMPs have breached the bacterial membrane barriers, vibrios can use RND pumps similar to those of other species to transport AMPs out of their cytoplasmic space. Although suppression of AMP transcription has been described in some host&#x02013;pathogen interactions, this mechanism of immune evasion appears to be more specific to given strains/species than universal among vibrios.</p></sec></body><back><ack><title>Acknowledgments</title><p>We acknowledge the REVAResp project (Resistance and EVAsion from the host antimicrobial RESPonse) funded by the Languedoc-Roussillon region as well as the Vibriogen project (ANR-11-BSV7-0023) funded by the ANR for financial support.</p></ack><notes><title>Author Contributions</title><p>All authors have contributed to the research presented and the writing of the present review.</p></notes><notes><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-antibiotics-03-00540"><label>1.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schmitt</surname><given-names>P.</given-names></name><name><surname>Rosa</surname><given-names>R.D.</given-names></name><name><surname>Duperthuy</surname><given-names>M.</given-names></name><name><surname>de Lorgeril</surname><given-names>J.</given-names></name><name><surname>Bachere</surname><given-names>E.</given-names></name><name><surname>Destoumieux-Garzon</surname><given-names>D.</given-names></name></person-group>
<article-title>The antimicrobial defense of the pacific oyster, <italic>Crassostrea gigas</italic>. How diversity may compensate for scarcity in the regulation of resident/pathogenic microflora</article-title>
<source>Front. Microbiol.</source>
<year>2012</year>
<volume>3</volume>
<fpage>e160</fpage>
<pub-id pub-id-type="doi">10.3389/fmicb.2012.00160</pub-id>
</element-citation></ref><ref id="B2-antibiotics-03-00540"><label>2.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jutla</surname><given-names>A.</given-names></name><name><surname>Whitcombe</surname><given-names>E.</given-names></name><name><surname>Hasan</surname><given-names>N.</given-names></name><name><surname>Haley</surname><given-names>B.</given-names></name><name><surname>Akanda</surname><given-names>A.</given-names></name><name><surname>Huq</surname><given-names>A.</given-names></name><name><surname>Alam</surname><given-names>M.</given-names></name><name><surname>Sack</surname><given-names>R.B.</given-names></name><name><surname>Colwell</surname><given-names>R.</given-names></name></person-group>
<article-title>Environmental factors influencing epidemic cholera</article-title>
<source>Am. J. Trop. Med. Hyg.</source>
<year>2013</year>
<volume>89</volume>
<fpage>597</fpage>
<lpage>607</lpage>
<pub-id pub-id-type="doi">10.4269/ajtmh.12-0721</pub-id>
<?supplied-pmid 23897993?><pub-id pub-id-type="pmid">23897993</pub-id></element-citation></ref><ref id="B3-antibiotics-03-00540"><label>3.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ganz</surname><given-names>T.</given-names></name></person-group>
<article-title>Defensins: Antimicrobial peptides of innate immunity</article-title>
<source>Nat. Rev. Immunol.</source>
<year>2003</year>
<volume>3</volume>
<fpage>710</fpage>
<lpage>720</lpage>
<pub-id pub-id-type="doi">10.1038/nri1180</pub-id>
<?supplied-pmid 12949495?><pub-id pub-id-type="pmid">12949495</pub-id></element-citation></ref><ref id="B4-antibiotics-03-00540"><label>4.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gallo</surname><given-names>R.L.</given-names></name><name><surname>Hooper</surname><given-names>L.V.</given-names></name></person-group>
<article-title>Epithelial antimicrobial defence of the skin and intestine</article-title>
<source>Nat. Rev. Immunol.</source>
<year>2012</year>
<volume>12</volume>
<fpage>503</fpage>
<lpage>516</lpage>
<pub-id pub-id-type="doi">10.1038/nri3228</pub-id>
<?supplied-pmid 22728527?><pub-id pub-id-type="pmid">22728527</pub-id></element-citation></ref><ref id="B5-antibiotics-03-00540"><label>5.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ma</surname><given-names>A.T.</given-names></name><name><surname>McAuley</surname><given-names>S.</given-names></name><name><surname>Pukatzki</surname><given-names>S.</given-names></name><name><surname>Mekalanos</surname><given-names>J.J.</given-names></name></person-group>
<article-title>Translocation of a <italic>Vibrio cholerae</italic> type vi secretion effector requires bacterial endocytosis by host cells</article-title>
<source>Cell Host Microbe</source>
<year>2009</year>
<volume>5</volume>
<fpage>234</fpage>
<lpage>243</lpage>
<pub-id pub-id-type="doi">10.1016/j.chom.2009.02.005</pub-id>
<?supplied-pmid 19286133?><pub-id pub-id-type="pmid">19286133</pub-id></element-citation></ref><ref id="B6-antibiotics-03-00540"><label>6.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Duperthuy</surname><given-names>M.</given-names></name><name><surname>Schmitt</surname><given-names>P.</given-names></name><name><surname>Garzon</surname><given-names>E.</given-names></name><name><surname>Caro</surname><given-names>A.</given-names></name><name><surname>Rosa</surname><given-names>R.D.</given-names></name><name><surname>Le Roux</surname><given-names>F.</given-names></name><name><surname>Lautredou-Audouy</surname><given-names>N.</given-names></name><name><surname>Got</surname><given-names>P.</given-names></name><name><surname>Romestand</surname><given-names>B.</given-names></name><name><surname>de Lorgeril</surname><given-names>J.</given-names></name><etal/></person-group>
<article-title>Use of ompu porins for attachment and invasion of <italic>Crassostrea gigas</italic> immune cells by the oyster pathogen <italic>Vibrio splendidus</italic></article-title>
<source>Proc. Natl. Acad. Sci. USA</source>
<year>2011</year>
<volume>108</volume>
<fpage>2993</fpage>
<lpage>2998</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1015326108</pub-id>
<?supplied-pmid 21282662?><pub-id pub-id-type="pmid">21282662</pub-id></element-citation></ref><ref id="B7-antibiotics-03-00540"><label>7.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brogden</surname><given-names>K.A.</given-names></name></person-group>
<article-title>Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria?</article-title>
<source>Nat. Rev. Microbiol.</source>
<year>2005</year>
<volume>3</volume>
<fpage>238</fpage>
<lpage>250</lpage>
<pub-id pub-id-type="pmid">15703760</pub-id></element-citation></ref><ref id="B8-antibiotics-03-00540"><label>8.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kragol</surname><given-names>G.</given-names></name><name><surname>Lovas</surname><given-names>S.</given-names></name><name><surname>Varadi</surname><given-names>G.</given-names></name><name><surname>Condie</surname><given-names>B.A.</given-names></name><name><surname>Hoffmann</surname><given-names>R.</given-names></name><name><surname>Otvos</surname><given-names>L.</given-names><suffix>Jr.</suffix></name></person-group>
<article-title>The antibacterial peptide pyrrhocoricin inhibits the ATPase actions of DnaK and prevents chaperone-assisted protein folding</article-title>
<source>Biochemistry</source>
<year>2001</year>
<volume>40</volume>
<fpage>3016</fpage>
<lpage>3026</lpage>
<pub-id pub-id-type="doi">10.1021/bi002656a</pub-id>
<?supplied-pmid 11258915?><pub-id pub-id-type="pmid">11258915</pub-id></element-citation></ref><ref id="B9-antibiotics-03-00540"><label>9.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brotz</surname><given-names>H.</given-names></name><name><surname>Josten</surname><given-names>M.</given-names></name><name><surname>Wiedemann</surname><given-names>I.</given-names></name><name><surname>Schneider</surname><given-names>U.</given-names></name><name><surname>Gotz</surname><given-names>F.</given-names></name><name><surname>Bierbaum</surname><given-names>G.</given-names></name><name><surname>Sahl</surname><given-names>H.G.</given-names></name></person-group>
<article-title>Role of lipid-bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics</article-title>
<source>Mol. Microbiol.</source>
<year>1998</year>
<volume>30</volume>
<fpage>317</fpage>
<lpage>327</lpage>
<pub-id pub-id-type="doi">10.1046/j.1365-2958.1998.01065.x</pub-id>
<?supplied-pmid 9791177?><pub-id pub-id-type="pmid">9791177</pub-id></element-citation></ref><ref id="B10-antibiotics-03-00540"><label>10.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Park</surname><given-names>C.B.</given-names></name><name><surname>Kim</surname><given-names>H.S.</given-names></name><name><surname>Kim</surname><given-names>S.C.</given-names></name></person-group>
<article-title>Mechanism of action of the antimicrobial peptide buforin II: Buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions</article-title>
<source>Biochem. Biophys. Res. Commun.</source>
<year>1998</year>
<volume>244</volume>
<fpage>253</fpage>
<lpage>257</lpage>
<pub-id pub-id-type="doi">10.1006/bbrc.1998.8159</pub-id>
<?supplied-pmid 9514864?><pub-id pub-id-type="pmid">9514864</pub-id></element-citation></ref><ref id="B11-antibiotics-03-00540"><label>11.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Patrzykat</surname><given-names>A.</given-names></name><name><surname>Friedrich</surname><given-names>C.L.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Mendoza</surname><given-names>V.</given-names></name><name><surname>Hancock</surname><given-names>R.E.</given-names></name></person-group>
<article-title>Sublethal concentrations of pleurocidin-derived antimicrobial peptides inhibit macromolecular synthesis in <italic>Escherichia coli.</italic></article-title>
<source>Antimicrob. Agents Chemother.</source>
<year>2002</year>
<volume>46</volume>
<fpage>605</fpage>
<lpage>614</lpage>
<pub-id pub-id-type="doi">10.1128/AAC.46.3.605-614.2002</pub-id>
<?supplied-pmid 11850238?><pub-id pub-id-type="pmid">11850238</pub-id></element-citation></ref><ref id="B12-antibiotics-03-00540"><label>12.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Srinivasan</surname><given-names>S.</given-names></name><name><surname>Beema Shafreen</surname><given-names>R.M.</given-names></name><name><surname>Nithyanand</surname><given-names>P.</given-names></name><name><surname>Manisankar</surname><given-names>P.</given-names></name><name><surname>Pandian</surname><given-names>S.K.</given-names></name></person-group>
<article-title>Synthesis and <italic>in vitro</italic> antimicrobial evaluation of novel fluoroquinolone derivatives</article-title>
<source>Eur. J. Med. Chem.</source>
<year>2010</year>
<volume>45</volume>
<fpage>6101</fpage>
<lpage>6105</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejmech.2010.09.036</pub-id>
<?supplied-pmid 20933306?><pub-id pub-id-type="pmid">20933306</pub-id></element-citation></ref><ref id="B13-antibiotics-03-00540"><label>13.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wilmes</surname><given-names>M.</given-names></name><name><surname>Cammue</surname><given-names>B.P.</given-names></name><name><surname>Sahl</surname><given-names>H.G.</given-names></name><name><surname>Thevissen</surname><given-names>K.</given-names></name></person-group>
<article-title>Antibiotic activities of host defense peptides: More to it than lipid bilayer perturbation</article-title>
<source>Nat. Prod. Rep.</source>
<year>2011</year>
<volume>28</volume>
<fpage>1350</fpage>
<lpage>1358</lpage>
<pub-id pub-id-type="doi">10.1039/c1np00022e</pub-id>
<?supplied-pmid 21617811?><pub-id pub-id-type="pmid">21617811</pub-id></element-citation></ref><ref id="B14-antibiotics-03-00540"><label>14.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schmitt</surname><given-names>P.</given-names></name><name><surname>de Lorgeril</surname><given-names>J.</given-names></name><name><surname>Gueguen</surname><given-names>Y.</given-names></name><name><surname>Destoumieux-Garzon</surname><given-names>D.</given-names></name><name><surname>Bachere</surname><given-names>E.</given-names></name></person-group>
<article-title>Expression, tissue localization and synergy of antimicrobial peptides and proteins in the immune response of the oyster <italic>Crassostrea gigas</italic></article-title>
<source>Dev. Comp. Immunol.</source>
<year>2012</year>
<volume>37</volume>
<fpage>363</fpage>
<lpage>370</lpage>
<pub-id pub-id-type="doi">10.1016/j.dci.2012.01.004</pub-id>
<?supplied-pmid 22327168?><pub-id pub-id-type="pmid">22327168</pub-id></element-citation></ref><ref id="B15-antibiotics-03-00540"><label>15.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hilchie</surname><given-names>A.L.</given-names></name><name><surname>Wuerth</surname><given-names>K.</given-names></name><name><surname>Hancock</surname><given-names>R.E.</given-names></name></person-group>
<article-title>Immune modulation by multifaceted cationic host defense (antimicrobial) peptides</article-title>
<source>Nat. Chem. Biol.</source>
<year>2013</year>
<volume>9</volume>
<fpage>761</fpage>
<lpage>768</lpage>
<pub-id pub-id-type="doi">10.1038/nchembio.1393</pub-id>
<?supplied-pmid 24231617?><pub-id pub-id-type="pmid">24231617</pub-id></element-citation></ref><ref id="B16-antibiotics-03-00540"><label>16.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Duquesne</surname><given-names>S.</given-names></name><name><surname>Destoumieux-Garzon</surname><given-names>D.</given-names></name><name><surname>Peduzzi</surname><given-names>J.</given-names></name><name><surname>Rebuffat</surname><given-names>S.</given-names></name></person-group>
<article-title>Microcins, gene-encoded antibacterial peptides from enterobacteria</article-title>
<source>Nat. Prod. Rep.</source>
<year>2007</year>
<volume>24</volume>
<fpage>708</fpage>
<lpage>734</lpage>
<pub-id pub-id-type="doi">10.1039/b516237h</pub-id>
<?supplied-pmid 17653356?><pub-id pub-id-type="pmid">17653356</pub-id></element-citation></ref><ref id="B17-antibiotics-03-00540"><label>17.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cotter</surname><given-names>P.D.</given-names></name><name><surname>Ross</surname><given-names>R.P.</given-names></name><name><surname>Hill</surname><given-names>C.</given-names></name></person-group>
<article-title>Bacteriocins&#x02014;A viable alternative to antibiotics?</article-title>
<source>Nat. Rev. Microbiol.</source>
<year>2013</year>
<volume>11</volume>
<fpage>95</fpage>
<lpage>105</lpage>
<pub-id pub-id-type="pmid">23268227</pub-id></element-citation></ref><ref id="B18-antibiotics-03-00540"><label>18.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Martinez</surname><given-names>J.L.</given-names></name></person-group>
<article-title>Environmental pollution by antibiotics and by antibiotic resistance determinants</article-title>
<source>Environ. Pollut.</source>
<year>2009</year>
<volume>157</volume>
<fpage>2893</fpage>
<lpage>2902</lpage>
<pub-id pub-id-type="doi">10.1016/j.envpol.2009.05.051</pub-id>
<?supplied-pmid 19560847?><pub-id pub-id-type="pmid">19560847</pub-id></element-citation></ref><ref id="B19-antibiotics-03-00540"><label>19.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Qadri</surname><given-names>F.</given-names></name><name><surname>Alam</surname><given-names>M.S.</given-names></name><name><surname>Nishibuchi</surname><given-names>M.</given-names></name><name><surname>Rahman</surname><given-names>T.</given-names></name><name><surname>Alam</surname><given-names>N.H.</given-names></name><name><surname>Chisti</surname><given-names>J.</given-names></name><name><surname>Kondo</surname><given-names>S.</given-names></name><name><surname>Sugiyama</surname><given-names>J.</given-names></name><name><surname>Bhuiyan</surname><given-names>N.A.</given-names></name><name><surname>Mathan</surname><given-names>M.M.</given-names></name><etal/></person-group>
<article-title>Adaptive and inflammatory immune responses in patients infected with strains of <italic>Vibrio parahaemolyticus</italic></article-title>
<source>J. Infect. Dis.</source>
<year>2003</year>
<volume>187</volume>
<fpage>1085</fpage>
<lpage>1096</lpage>
<pub-id pub-id-type="doi">10.1086/368257</pub-id>
<?supplied-pmid 12660923?><pub-id pub-id-type="pmid">12660923</pub-id></element-citation></ref><ref id="B20-antibiotics-03-00540"><label>20.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Qadri</surname><given-names>F.</given-names></name><name><surname>Bhuiyan</surname><given-names>T.R.</given-names></name><name><surname>Dutta</surname><given-names>K.K.</given-names></name><name><surname>Raqib</surname><given-names>R.</given-names></name><name><surname>Alam</surname><given-names>M.S.</given-names></name><name><surname>Alam</surname><given-names>N.H.</given-names></name><name><surname>Svennerholm</surname><given-names>A.M.</given-names></name><name><surname>Mathan</surname><given-names>M.M.</given-names></name></person-group>
<article-title>Acute dehydrating disease caused by <italic>Vibrio cholerae</italic> serogroups o1 and o139 induce increases in innate cells and inflammatory mediators at the mucosal surface of the gut</article-title>
<source>Gut</source>
<year>2004</year>
<volume>53</volume>
<fpage>62</fpage>
<lpage>69</lpage>
<pub-id pub-id-type="doi">10.1136/gut.53.1.62</pub-id>
<?supplied-pmid 14684578?><pub-id pub-id-type="pmid">14684578</pub-id></element-citation></ref><ref id="B21-antibiotics-03-00540"><label>21.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vanden Broeck</surname><given-names>D.</given-names></name><name><surname>Horvath</surname><given-names>C.</given-names></name><name><surname>de Wolf</surname><given-names>M.J.</given-names></name></person-group>
<article-title><italic>Vibrio cholerae</italic>: Cholera toxin</article-title>
<source>Int. J. Biochem. Cell. Biol.</source>
<year>2007</year>
<volume>39</volume>
<fpage>1771</fpage>
<lpage>1775</lpage>
<pub-id pub-id-type="doi">10.1016/j.biocel.2007.07.005</pub-id>
<?supplied-pmid 17716938?><pub-id pub-id-type="pmid">17716938</pub-id></element-citation></ref><ref id="B22-antibiotics-03-00540"><label>22.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Park</surname><given-names>K.S.</given-names></name><name><surname>Ono</surname><given-names>T.</given-names></name><name><surname>Rokuda</surname><given-names>M.</given-names></name><name><surname>Jang</surname><given-names>M.H.</given-names></name><name><surname>Okada</surname><given-names>K.</given-names></name><name><surname>Iida</surname><given-names>T.</given-names></name><name><surname>Honda</surname><given-names>T.</given-names></name></person-group>
<article-title>Functional characterization of two type III secretion systems of vibrio parahaemolyticus</article-title>
<source>Infect. Immun.</source>
<year>2004</year>
<volume>72</volume>
<fpage>6659</fpage>
<lpage>6665</lpage>
<pub-id pub-id-type="doi">10.1128/IAI.72.11.6659-6665.2004</pub-id>
<?supplied-pmid 15501799?><pub-id pub-id-type="pmid">15501799</pub-id></element-citation></ref><ref id="B23-antibiotics-03-00540"><label>23.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhou</surname><given-names>X.</given-names></name><name><surname>Gewurz</surname><given-names>B.E.</given-names></name><name><surname>Ritchie</surname><given-names>J.M.</given-names></name><name><surname>Takasaki</surname><given-names>K.</given-names></name><name><surname>Greenfeld</surname><given-names>H.</given-names></name><name><surname>Kieff</surname><given-names>E.</given-names></name><name><surname>Davis</surname><given-names>B.M.</given-names></name><name><surname>Waldor</surname><given-names>M.K.</given-names></name></person-group>
<article-title>A <italic>Vibrio parahaemolyticus</italic> t3ss effector mediates pathogenesis by independently enabling intestinal colonization and inhibiting tak1 activation</article-title>
<source>Cell. Rep.</source>
<year>2013</year>
<volume>3</volume>
<fpage>1690</fpage>
<lpage>1702</lpage>
<pub-id pub-id-type="doi">10.1016/j.celrep.2013.03.039</pub-id>
<?supplied-pmid 23623501?><pub-id pub-id-type="pmid">23623501</pub-id></element-citation></ref><ref id="B24-antibiotics-03-00540"><label>24.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>McFall-Ngai</surname><given-names>M.</given-names></name><name><surname>Nyholm</surname><given-names>S.V.</given-names></name><name><surname>Castillo</surname><given-names>M.G.</given-names></name></person-group>
<article-title>The role of the immune system in the initiation and persistence of the euprymna scolopes&#x02014;<italic>Vibrio fischeri</italic> symbiosis</article-title>
<source>Semin. Immunol.</source>
<year>2010</year>
<volume>22</volume>
<fpage>48</fpage>
<lpage>53</lpage>
<pub-id pub-id-type="doi">10.1016/j.smim.2009.11.003</pub-id>
<?supplied-pmid 20036144?><pub-id pub-id-type="pmid">20036144</pub-id></element-citation></ref><ref id="B25-antibiotics-03-00540"><label>25.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Weber</surname><given-names>B.</given-names></name><name><surname>Chen</surname><given-names>C.</given-names></name><name><surname>Milton</surname><given-names>D.L.</given-names></name></person-group>
<article-title>Colonization of fish skin is vital for <italic>Vibrio anguillarum</italic> to cause disease</article-title>
<source>Environ. Microbiol. Rep.</source>
<year>2010</year>
<volume>2</volume>
<fpage>133</fpage>
<lpage>139</lpage>
<pub-id pub-id-type="doi">10.1111/j.1758-2229.2009.00120.x</pub-id>
<?supplied-pmid 23766008?><pub-id pub-id-type="pmid">23766008</pub-id></element-citation></ref><ref id="B26-antibiotics-03-00540"><label>26.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rosenberg</surname><given-names>E.</given-names></name><name><surname>Falkovitz</surname><given-names>L.</given-names></name></person-group>
<article-title>The <italic>Vibrio shiloi</italic> / <italic>Oculina patagonica</italic> model system of coral bleaching</article-title>
<source>Annu. Rev. Microbiol.</source>
<year>2004</year>
<volume>58</volume>
<fpage>143</fpage>
<lpage>159</lpage>
<pub-id pub-id-type="doi">10.1146/annurev.micro.58.030603.123610</pub-id>
<?supplied-pmid 15487933?><pub-id pub-id-type="pmid">15487933</pub-id></element-citation></ref><ref id="B27-antibiotics-03-00540"><label>27.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Daniels</surname><given-names>N.A.</given-names></name></person-group>
<article-title><italic>Vibrio vulnificus</italic> oysters: Pearls and perils</article-title>
<source>Clin. Infect. Dis.</source>
<year>2011</year>
<volume>52</volume>
<fpage>788</fpage>
<lpage>792</lpage>
<pub-id pub-id-type="doi">10.1093/cid/ciq251</pub-id>
<?supplied-pmid 21367733?><pub-id pub-id-type="pmid">21367733</pub-id></element-citation></ref><ref id="B28-antibiotics-03-00540"><label>28.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vidal-Dupiol</surname><given-names>J.</given-names></name><name><surname>Ladriere</surname><given-names>O.</given-names></name><name><surname>Destoumieux-Garzon</surname><given-names>D.</given-names></name><name><surname>Sautiere</surname><given-names>P.E.</given-names></name><name><surname>Meistertzheim</surname><given-names>A.L.</given-names></name><name><surname>Tambutte</surname><given-names>E.</given-names></name><name><surname>Tambutte</surname><given-names>S.</given-names></name><name><surname>Duval</surname><given-names>D.</given-names></name><name><surname>Foure</surname><given-names>L.</given-names></name><name><surname>Adjeroud</surname><given-names>M.</given-names></name><etal/></person-group>
<article-title>Innate immune responses of a scleractinian coral to vibriosis</article-title>
<source>J. Biol. Chem.</source>
<year>2011</year>
<volume>286</volume>
<fpage>22688</fpage>
<lpage>22698</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M110.216358</pub-id>
<?supplied-pmid 21536670?><pub-id pub-id-type="pmid">21536670</pub-id></element-citation></ref><ref id="B29-antibiotics-03-00540"><label>29.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pitman</surname><given-names>R.S.</given-names></name><name><surname>Blumberg</surname><given-names>R.S.</given-names></name></person-group>
<article-title>First line of defense: The role of the intestinal epithelium as an active component of the mucosal immune system</article-title>
<source>J. Gastroenterol.</source>
<year>2000</year>
<volume>35</volume>
<fpage>805</fpage>
<lpage>814</lpage>
<pub-id pub-id-type="doi">10.1007/s005350070017</pub-id>
<?supplied-pmid 11085489?><pub-id pub-id-type="pmid">11085489</pub-id></element-citation></ref><ref id="B30-antibiotics-03-00540"><label>30.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Levy</surname><given-names>O.</given-names></name><name><surname>Canny</surname><given-names>G.</given-names></name><name><surname>Serhan</surname><given-names>C.N.</given-names></name><name><surname>Colgan</surname><given-names>S.P.</given-names></name></person-group>
<article-title>Expression of bpi (bactericidal/permeability-increasing protein) in human mucosal epithelia</article-title>
<source>Biochem. Soc. Trans.</source>
<year>2003</year>
<volume>31</volume>
<fpage>795</fpage>
<lpage>800</lpage>
<pub-id pub-id-type="doi">10.1042/BST0310795</pub-id>
<?supplied-pmid 12887308?><pub-id pub-id-type="pmid">12887308</pub-id></element-citation></ref><ref id="B31-antibiotics-03-00540"><label>31.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bals</surname><given-names>R.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Zasloff</surname><given-names>M.</given-names></name><name><surname>Wilson</surname><given-names>J.M.</given-names></name></person-group>
<article-title>The peptide antibiotic ll-37/hcap-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface</article-title>
<source>Proc. Natl. Acad. Sci. USA</source>
<year>1998</year>
<volume>95</volume>
<fpage>9541</fpage>
<lpage>9546</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.95.16.9541</pub-id>
<?supplied-pmid 9689116?><pub-id pub-id-type="pmid">9689116</pub-id></element-citation></ref><ref id="B32-antibiotics-03-00540"><label>32.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Frohm Nilsson</surname><given-names>M.</given-names></name><name><surname>Sandstedt</surname><given-names>B.</given-names></name><name><surname>Sorensen</surname><given-names>O.</given-names></name><name><surname>Weber</surname><given-names>G.</given-names></name><name><surname>Borregaard</surname><given-names>N.</given-names></name><name><surname>Stahle-Backdahl</surname><given-names>M.</given-names></name></person-group>
<article-title>The human cationic antimicrobial protein (hcap18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6</article-title>
<source>Infect. Immun.</source>
<year>1999</year>
<volume>67</volume>
<fpage>2561</fpage>
<lpage>2566</lpage>
<?supplied-pmid 10225921?><pub-id pub-id-type="pmid">10225921</pub-id></element-citation></ref><ref id="B33-antibiotics-03-00540"><label>33.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bals</surname><given-names>R.</given-names></name><name><surname>Wilson</surname><given-names>J.M.</given-names></name></person-group>
<article-title>Cathelicidins&#x02014;A family of multifunctional antimicrobial peptides</article-title>
<source>Cell. Mol. Life Sci.</source>
<year>2003</year>
<volume>60</volume>
<fpage>711</fpage>
<lpage>720</lpage>
<pub-id pub-id-type="doi">10.1007/s00018-003-2186-9</pub-id>
<?supplied-pmid 12785718?><pub-id pub-id-type="pmid">12785718</pub-id></element-citation></ref><ref id="B34-antibiotics-03-00540"><label>34.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Frohm</surname><given-names>M.</given-names></name><name><surname>Agerberth</surname><given-names>B.</given-names></name><name><surname>Ahangari</surname><given-names>G.</given-names></name><name><surname>Stahle-Backdahl</surname><given-names>M.</given-names></name><name><surname>Liden</surname><given-names>S.</given-names></name><name><surname>Wigzell</surname><given-names>H.</given-names></name><name><surname>Gudmundsson</surname><given-names>G.H.</given-names></name></person-group>
<article-title>The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders</article-title>
<source>J. Biol. Chem.</source>
<year>1997</year>
<volume>272</volume>
<fpage>15258</fpage>
<lpage>15263</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.272.24.15258</pub-id>
<?supplied-pmid 9182550?><pub-id pub-id-type="pmid">9182550</pub-id></element-citation></ref><ref id="B35-antibiotics-03-00540"><label>35.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Scheetz</surname><given-names>T.</given-names></name><name><surname>Bartlett</surname><given-names>J.A.</given-names></name><name><surname>Walters</surname><given-names>J.D.</given-names></name><name><surname>Schutte</surname><given-names>B.C.</given-names></name><name><surname>Casavant</surname><given-names>T.L.</given-names></name><name><surname>McCray</surname><given-names>P.B.</given-names><suffix>Jr.</suffix></name></person-group>
<article-title>Genomics-based approaches to gene discovery in innate immunity</article-title>
<source>Immunol. Rev.</source>
<year>2002</year>
<volume>190</volume>
<fpage>137</fpage>
<lpage>145</lpage>
<pub-id pub-id-type="doi">10.1034/j.1600-065X.2002.19010.x</pub-id>
<?supplied-pmid 12493011?><pub-id pub-id-type="pmid">12493011</pub-id></element-citation></ref><ref id="B36-antibiotics-03-00540"><label>36.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cash</surname><given-names>H.L.</given-names></name><name><surname>Whitham</surname><given-names>C.V.</given-names></name><name><surname>Behrendt</surname><given-names>C.L.</given-names></name><name><surname>Hooper</surname><given-names>L.V.</given-names></name></person-group>
<article-title>Symbiotic bacteria direct expression of an intestinal bactericidal lectin</article-title>
<source>Science</source>
<year>2006</year>
<volume>313</volume>
<fpage>1126</fpage>
<lpage>1130</lpage>
<pub-id pub-id-type="doi">10.1126/science.1127119</pub-id>
<?supplied-pmid 16931762?><pub-id pub-id-type="pmid">16931762</pub-id></element-citation></ref><ref id="B37-antibiotics-03-00540"><label>37.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ouellette</surname><given-names>A.J.</given-names></name></person-group>
<article-title>Paneth cell alpha-defensins in enteric innate immunity</article-title>
<source>Cell. Mol. Life Sci.</source>
<year>2011</year>
<volume>68</volume>
<fpage>2215</fpage>
<lpage>2229</lpage>
<pub-id pub-id-type="doi">10.1007/s00018-011-0714-6</pub-id>
<?supplied-pmid 21560070?><pub-id pub-id-type="pmid">21560070</pub-id></element-citation></ref><ref id="B38-antibiotics-03-00540"><label>38.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pukatzki</surname><given-names>S.</given-names></name><name><surname>Provenzano</surname><given-names>D.</given-names></name></person-group>
<article-title><italic>Vibrio cholerae</italic> as a predator: Lessons from evolutionary principles</article-title>
<source>Front. Microbiol.</source>
<year>2013</year>
<volume>4</volume>
<fpage>e384</fpage>
<pub-id pub-id-type="doi">10.3389/fmicb.2013.00384</pub-id>
</element-citation></ref><ref id="B39-antibiotics-03-00540"><label>39.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Salzman</surname><given-names>N.H.</given-names></name><name><surname>Ghosh</surname><given-names>D.</given-names></name><name><surname>Huttner</surname><given-names>K.M.</given-names></name><name><surname>Paterson</surname><given-names>Y.</given-names></name><name><surname>Bevins</surname><given-names>C.L.</given-names></name></person-group>
<article-title>Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin</article-title>
<source>Nature</source>
<year>2003</year>
<volume>422</volume>
<fpage>522</fpage>
<lpage>526</lpage>
<pub-id pub-id-type="doi">10.1038/nature01520</pub-id>
<?supplied-pmid 12660734?><pub-id pub-id-type="pmid">12660734</pub-id></element-citation></ref><ref id="B40-antibiotics-03-00540"><label>40.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chu</surname><given-names>H.</given-names></name><name><surname>Pazgier</surname><given-names>M.</given-names></name><name><surname>Jung</surname><given-names>G.</given-names></name><name><surname>Nuccio</surname><given-names>S.P.</given-names></name><name><surname>Castillo</surname><given-names>P.A.</given-names></name><name><surname>de Jong</surname><given-names>M.F.</given-names></name><name><surname>Winter</surname><given-names>M.G.</given-names></name><name><surname>Winter</surname><given-names>S.E.</given-names></name><name><surname>Wehkamp</surname><given-names>J.</given-names></name><name><surname>Shen</surname><given-names>B.</given-names></name><etal/></person-group>
<article-title>Human alpha-defensin 6 promotes mucosal innate immunity through self-assembled peptide nanonets</article-title>
<source>Science</source>
<year>2012</year>
<volume>337</volume>
<fpage>477</fpage>
<lpage>481</lpage>
<pub-id pub-id-type="doi">10.1126/science.1218831</pub-id>
<?supplied-pmid 22722251?><pub-id pub-id-type="pmid">22722251</pub-id></element-citation></ref><ref id="B41-antibiotics-03-00540"><label>41.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shin</surname><given-names>O.S.</given-names></name><name><surname>Uddin</surname><given-names>T.</given-names></name><name><surname>Citorik</surname><given-names>R.</given-names></name><name><surname>Wang</surname><given-names>J.P.</given-names></name><name><surname>della Pelle</surname><given-names>P.</given-names></name><name><surname>Kradin</surname><given-names>R.L.</given-names></name><name><surname>Bingle</surname><given-names>C.D.</given-names></name><name><surname>Bingle</surname><given-names>L.</given-names></name><name><surname>Camilli</surname><given-names>A.</given-names></name><name><surname>Bhuiyan</surname><given-names>T.R.</given-names></name><etal/></person-group>
<article-title>Lplunc1 modulates innate immune responses to <italic>Vibrio cholerae</italic></article-title>
<source>J. Infect. Dis.</source>
<year>2011</year>
<volume>204</volume>
<fpage>1349</fpage>
<lpage>1357</lpage>
<pub-id pub-id-type="doi">10.1093/infdis/jir544</pub-id>
<?supplied-pmid 21900486?><pub-id pub-id-type="pmid">21900486</pub-id></element-citation></ref><ref id="B42-antibiotics-03-00540"><label>42.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Masso-Silva</surname><given-names>J.A.</given-names></name><name><surname>Diamond</surname><given-names>G.</given-names></name></person-group>
<article-title>Antimicrobial peptides from fish</article-title>
<source>Pharmaceuticals</source>
<year>2014</year>
<volume>7</volume>
<fpage>265</fpage>
<lpage>310</lpage>
<pub-id pub-id-type="doi">10.3390/ph7030265</pub-id>
<?supplied-pmid 24594555?><pub-id pub-id-type="pmid">24594555</pub-id></element-citation></ref><ref id="B43-antibiotics-03-00540"><label>43.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rakers</surname><given-names>S.</given-names></name><name><surname>Niklasson</surname><given-names>L.</given-names></name><name><surname>Steinhagen</surname><given-names>D.</given-names></name><name><surname>Kruse</surname><given-names>C.</given-names></name><name><surname>Schauber</surname><given-names>J.</given-names></name><name><surname>Sundell</surname><given-names>K.</given-names></name><name><surname>Paus</surname><given-names>R.</given-names></name></person-group>
<article-title>Antimicrobial peptides (amps) from fish epidermis: Perspectives for investigative dermatology</article-title>
<source>J. Invest. Dermatol.</source>
<year>2013</year>
<volume>133</volume>
<fpage>1140</fpage>
<lpage>1149</lpage>
<pub-id pub-id-type="doi">10.1038/jid.2012.503</pub-id>
<?supplied-pmid 23407389?><pub-id pub-id-type="pmid">23407389</pub-id></element-citation></ref><ref id="B44-antibiotics-03-00540"><label>44.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Smith</surname><given-names>V.J.</given-names></name><name><surname>Desbois</surname><given-names>A.P.</given-names></name><name><surname>Dyrynda</surname><given-names>E.A.</given-names></name></person-group>
<article-title>Conventional and unconventional antimicrobials from fish, marine invertebrates and micro-algae</article-title>
<source>Mar. Drugs.</source>
<year>2010</year>
<volume>8</volume>
<fpage>1213</fpage>
<lpage>1262</lpage>
<pub-id pub-id-type="doi">10.3390/md8041213</pub-id>
<?supplied-pmid 20479976?><pub-id pub-id-type="pmid">20479976</pub-id></element-citation></ref><ref id="B45-antibiotics-03-00540"><label>45.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Casadei</surname><given-names>E.</given-names></name><name><surname>Wang</surname><given-names>T.</given-names></name><name><surname>Zou</surname><given-names>J.</given-names></name><name><surname>Gonzalez Vecino</surname><given-names>J.L.</given-names></name><name><surname>Wadsworth</surname><given-names>S.</given-names></name><name><surname>Secombes</surname><given-names>C.J.</given-names></name></person-group>
<article-title>Characterization of three novel beta-defensin antimicrobial peptides in rainbow trout (<italic>Oncorhynchus mykiss</italic>)</article-title>
<source>Mol. Immunol.</source>
<year>2009</year>
<volume>46</volume>
<fpage>3358</fpage>
<lpage>3366</lpage>
<pub-id pub-id-type="doi">10.1016/j.molimm.2009.07.018</pub-id>
<?supplied-pmid 19709750?><pub-id pub-id-type="pmid">19709750</pub-id></element-citation></ref><ref id="B46-antibiotics-03-00540"><label>46.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Caipang</surname><given-names>C.M.</given-names></name><name><surname>Lazado</surname><given-names>C.C.</given-names></name><name><surname>Brinchmann</surname><given-names>M.F.</given-names></name><name><surname>Kiron</surname><given-names>V.</given-names></name></person-group>
<article-title>Infection-induced changes in expression of antibacterial and cytokine genes in the gill epithelial cells of Atlantic cod, <italic>Gadus morhua</italic> during incubation with bacterial pathogens</article-title>
<source>Comp. Biochem. Physiol. B Biochem. Mol. Biol.</source>
<year>2010</year>
<volume>156</volume>
<fpage>319</fpage>
<lpage>325</lpage>
<pub-id pub-id-type="doi">10.1016/j.cbpb.2010.04.009</pub-id>
<?supplied-pmid 20430108?><pub-id pub-id-type="pmid">20430108</pub-id></element-citation></ref><ref id="B47-antibiotics-03-00540"><label>47.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chang</surname><given-names>C.I.</given-names></name><name><surname>Zhang</surname><given-names>Y.A.</given-names></name><name><surname>Zou</surname><given-names>J.</given-names></name><name><surname>Nie</surname><given-names>P.</given-names></name><name><surname>Secombes</surname><given-names>C.J.</given-names></name></person-group>
<article-title>Two cathelicidin genes are present in both rainbow trout (<italic>Oncorhynchus mykiss</italic>) and Atlantic salmon (<italic>Salmo salar</italic>)</article-title>
<source>Antimicrob. Agents Chemother.</source>
<year>2006</year>
<volume>50</volume>
<fpage>185</fpage>
<lpage>195</lpage>
<pub-id pub-id-type="doi">10.1128/AAC.50.1.185-195.2006</pub-id>
<?supplied-pmid 16377685?><pub-id pub-id-type="pmid">16377685</pub-id></element-citation></ref><ref id="B48-antibiotics-03-00540"><label>48.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kono</surname><given-names>T.</given-names></name><name><surname>Sakai</surname><given-names>M.</given-names></name></person-group>
<article-title>Molecular cloning of a novel bactericidal permeability-increasing protein/lipopolysaccharide-binding protein (bpi/lbp) from common carp <italic>Cyprinus carpio</italic> l. and its expression</article-title>
<source>Mol. Immunol.</source>
<year>2003</year>
<volume>40</volume>
<fpage>269</fpage>
<lpage>278</lpage>
<pub-id pub-id-type="doi">10.1016/S0161-5890(03)00103-2</pub-id>
<?supplied-pmid 12943799?><pub-id pub-id-type="pmid">12943799</pub-id></element-citation></ref><ref id="B49-antibiotics-03-00540"><label>49.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Stenvik</surname><given-names>J.</given-names></name><name><surname>Solstad</surname><given-names>T.</given-names></name><name><surname>Strand</surname><given-names>C.</given-names></name><name><surname>Leiros</surname><given-names>I.</given-names></name><name><surname>Jorgensen</surname><given-names>T.T.</given-names></name></person-group>
<article-title>Cloning and analyses of a bpi/lbp cDNA of the Atlantic cod (<italic>Gadus morhua</italic> L.)</article-title>
<source>Dev. Comp. Immunol.</source>
<year>2004</year>
<volume>28</volume>
<fpage>307</fpage>
<lpage>323</lpage>
<pub-id pub-id-type="doi">10.1016/j.dci.2003.09.002</pub-id>
<?supplied-pmid 14698217?><pub-id pub-id-type="pmid">14698217</pub-id></element-citation></ref><ref id="B50-antibiotics-03-00540"><label>50.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cho</surname><given-names>J.H.</given-names></name><name><surname>Park</surname><given-names>I.Y.</given-names></name><name><surname>Kim</surname><given-names>H.S.</given-names></name><name><surname>Lee</surname><given-names>W.T.</given-names></name><name><surname>Kim</surname><given-names>M.S.</given-names></name><name><surname>Kim</surname><given-names>S.C.</given-names></name></person-group>
<article-title>Cathepsin D produces antimicrobial peptide parasin I from histone H2A in the skin mucosa of fish</article-title>
<source>FASEB J.</source>
<year>2002</year>
<volume>16</volume>
<fpage>429</fpage>
<lpage>431</lpage>
<?supplied-pmid 11821259?><pub-id pub-id-type="pmid">11821259</pub-id></element-citation></ref><ref id="B51-antibiotics-03-00540"><label>51.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Krasity</surname><given-names>B.C.</given-names></name><name><surname>Troll</surname><given-names>J.V.</given-names></name><name><surname>Weiss</surname><given-names>J.P.</given-names></name><name><surname>McFall-Ngai</surname><given-names>M.J.</given-names></name></person-group>
<article-title>Lbp/bpi proteins and their relatives: Conservation over evolution and roles in mutualism</article-title>
<source>Biochem. Soc. Trans.</source>
<year>2011</year>
<volume>39</volume>
<fpage>1039</fpage>
<lpage>1044</lpage>
<pub-id pub-id-type="doi">10.1042/BST0391039</pub-id>
<?supplied-pmid 21787344?><pub-id pub-id-type="pmid">21787344</pub-id></element-citation></ref><ref id="B52-antibiotics-03-00540"><label>52.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gonzalez</surname><given-names>M.</given-names></name><name><surname>Gueguen</surname><given-names>Y.</given-names></name><name><surname>Destoumieux-Garzon</surname><given-names>D.</given-names></name><name><surname>Romestand</surname><given-names>B.</given-names></name><name><surname>Fievet</surname><given-names>J.</given-names></name><name><surname>Pugniere</surname><given-names>M.</given-names></name><name><surname>Roquet</surname><given-names>F.</given-names></name><name><surname>Escoubas</surname><given-names>J.M.</given-names></name><name><surname>Vandenbulcke</surname><given-names>F.</given-names></name><name><surname>Levy</surname><given-names>O.</given-names></name><etal/></person-group>
<article-title>Evidence of a bactericidal permeability increasing protein in an invertebrate, the <italic>Crassostrea gigas</italic> Cg-BPI</article-title>
<source>Proc. Natl. Acad. Sci. USA</source>
<year>2007</year>
<volume>104</volume>
<fpage>17759</fpage>
<lpage>17764</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0702281104</pub-id>
<?supplied-pmid 17965238?><pub-id pub-id-type="pmid">17965238</pub-id></element-citation></ref><ref id="B53-antibiotics-03-00540"><label>53.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gueguen</surname><given-names>Y.</given-names></name><name><surname>Herpin</surname><given-names>A.</given-names></name><name><surname>Aumelas</surname><given-names>A.</given-names></name><name><surname>Garnier</surname><given-names>J.</given-names></name><name><surname>Fievet</surname><given-names>J.</given-names></name><name><surname>Escoubas</surname><given-names>J.M.</given-names></name><name><surname>Bulet</surname><given-names>P.</given-names></name><name><surname>Gonzalez</surname><given-names>M.</given-names></name><name><surname>Lelong</surname><given-names>C.</given-names></name><name><surname>Favrel</surname><given-names>P.</given-names></name><etal/></person-group>
<article-title>Characterization of a defensin from the oyster <italic>Crassostrea gigas</italic>. Recombinant production, folding, solution structure, antimicrobial activities, and gene expression</article-title>
<source>J. Biol. Chem.</source>
<year>2006</year>
<volume>281</volume>
<fpage>313</fpage>
<lpage>323</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M510850200</pub-id>
<?supplied-pmid 16246846?><pub-id pub-id-type="pmid">16246846</pub-id></element-citation></ref><ref id="B54-antibiotics-03-00540"><label>54.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Seo</surname><given-names>J.K.</given-names></name><name><surname>Lee</surname><given-names>M.J.</given-names></name><name><surname>Nam</surname><given-names>B.H.</given-names></name><name><surname>Park</surname><given-names>N.G.</given-names></name></person-group>
<article-title><italic>Cg</italic>molluscidin, a novel dibasic residue repeat rich antimicrobial peptide, purified from the gill of the pacific oyster, <italic>Crassostrea gigas</italic></article-title>
<source>Fish Shellfish Immunol.</source>
<year>2013</year>
<volume>35</volume>
<fpage>480</fpage>
<lpage>488</lpage>
<pub-id pub-id-type="doi">10.1016/j.fsi.2013.05.010</pub-id>
<?supplied-pmid 23711469?><pub-id pub-id-type="pmid">23711469</pub-id></element-citation></ref><ref id="B55-antibiotics-03-00540"><label>55.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Seo</surname><given-names>J.K.</given-names></name><name><surname>Stephenson</surname><given-names>J.</given-names></name><name><surname>Noga</surname><given-names>E.J.</given-names></name></person-group>
<article-title>Multiple antibacterial histone H2B proteins are expressed in tissues of American oyster</article-title>
<source>Comp. Biochem. Physiol. B Biochem. Mol. Biol.</source>
<year>2011</year>
<volume>158</volume>
<fpage>223</fpage>
<lpage>229</lpage>
<pub-id pub-id-type="doi">10.1016/j.cbpb.2010.11.011</pub-id>
<?supplied-pmid 21145411?><pub-id pub-id-type="pmid">21145411</pub-id></element-citation></ref><ref id="B56-antibiotics-03-00540"><label>56.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Poirier</surname><given-names>A.C.</given-names></name><name><surname>Schmitt</surname><given-names>P.</given-names></name><name><surname>Rosa</surname><given-names>R.D.</given-names></name><name><surname>Vanhove</surname><given-names>A.S.</given-names></name><name><surname>Kieffer-Jaquinod</surname><given-names>S.</given-names></name><name><surname>Rubio</surname><given-names>T.P.</given-names></name><name><surname>Charriere</surname><given-names>G.M.</given-names></name><name><surname>Destoumieux-Garzon</surname><given-names>D.</given-names></name></person-group>
<article-title>Antimicrobial histones and DNA traps in invertebrate immunity: Evidences in <italic>Crassostrea gigas</italic></article-title>
<source>J. Biol. Chem.</source>
<year>2014</year>
<volume>289</volume>
<fpage>24821</fpage>
<lpage>24831</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M114.576546</pub-id>
<?supplied-pmid 25037219?><pub-id pub-id-type="pmid">25037219</pub-id></element-citation></ref><ref id="B57-antibiotics-03-00540"><label>57.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Quayle</surname><given-names>A.J.</given-names></name><name><surname>Porter</surname><given-names>E.M.</given-names></name><name><surname>Nussbaum</surname><given-names>A.A.</given-names></name><name><surname>Wang</surname><given-names>Y.M.</given-names></name><name><surname>Brabec</surname><given-names>C.</given-names></name><name><surname>Yip</surname><given-names>K.P.</given-names></name><name><surname>Mok</surname><given-names>S.C.</given-names></name></person-group>
<article-title>Gene expression, immunolocalization, and secretion of human defensin-5 in human female reproductive tract</article-title>
<source>Am. J. Pathol.</source>
<year>1998</year>
<volume>152</volume>
<fpage>1247</fpage>
<lpage>1258</lpage>
<?supplied-pmid 9588893?><pub-id pub-id-type="pmid">9588893</pub-id></element-citation></ref><ref id="B58-antibiotics-03-00540"><label>58.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Singh</surname><given-names>P.K.</given-names></name><name><surname>Jia</surname><given-names>H.P.</given-names></name><name><surname>Wiles</surname><given-names>K.</given-names></name><name><surname>Hesselberth</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Conway</surname><given-names>B.A.</given-names></name><name><surname>Greenberg</surname><given-names>E.P.</given-names></name><name><surname>Valore</surname><given-names>E.V.</given-names></name><name><surname>Welsh</surname><given-names>M.J.</given-names></name><name><surname>Ganz</surname><given-names>T.</given-names></name><etal/></person-group>
<article-title>Production of beta-defensins by human airway epithelia</article-title>
<source>Proc. Natl. Acad. Sci. USA</source>
<year>1998</year>
<volume>95</volume>
<fpage>14961</fpage>
<lpage>14966</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.95.25.14961</pub-id>
<?supplied-pmid 9843998?><pub-id pub-id-type="pmid">9843998</pub-id></element-citation></ref><ref id="B59-antibiotics-03-00540"><label>59.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhao</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>I.</given-names></name><name><surname>Lehrer</surname><given-names>R.I.</given-names></name></person-group>
<article-title>Widespread expression of beta-defensin hBD-1 in human secretory glands and epithelial cells</article-title>
<source>FEBS Lett.</source>
<year>1996</year>
<volume>396</volume>
<fpage>319</fpage>
<lpage>322</lpage>
<pub-id pub-id-type="doi">10.1016/0014-5793(96)01123-4</pub-id>
<?supplied-pmid 8915011?><pub-id pub-id-type="pmid">8915011</pub-id></element-citation></ref><ref id="B60-antibiotics-03-00540"><label>60.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mathews</surname><given-names>M.</given-names></name><name><surname>Jia</surname><given-names>H.P.</given-names></name><name><surname>Guthmiller</surname><given-names>J.M.</given-names></name><name><surname>Losh</surname><given-names>G.</given-names></name><name><surname>Graham</surname><given-names>S.</given-names></name><name><surname>Johnson</surname><given-names>G.K.</given-names></name><name><surname>Tack</surname><given-names>B.F.</given-names></name><name><surname>McCray</surname><given-names>P.B.</given-names><suffix>Jr.</suffix></name></person-group>
<article-title>Production of beta-defensin antimicrobial peptides by the oral mucosa and salivary glands</article-title>
<source>Infect. Immun.</source>
<year>1999</year>
<volume>67</volume>
<fpage>2740</fpage>
<lpage>2745</lpage>
<?supplied-pmid 10338476?><pub-id pub-id-type="pmid">10338476</pub-id></element-citation></ref><ref id="B61-antibiotics-03-00540"><label>61.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>O&#x02019;Neil</surname><given-names>D.A.</given-names></name><name><surname>Porter</surname><given-names>E.M.</given-names></name><name><surname>Elewaut</surname><given-names>D.</given-names></name><name><surname>Anderson</surname><given-names>G.M.</given-names></name><name><surname>Eckmann</surname><given-names>L.</given-names></name><name><surname>Ganz</surname><given-names>T.</given-names></name><name><surname>Kagnoff</surname><given-names>M.F.</given-names></name></person-group>
<article-title>Expression and regulation of the human beta-defensins HBD-1 and HBD-2 in intestinal epithelium</article-title>
<source>J. Immunol.</source>
<year>1999</year>
<volume>163</volume>
<fpage>6718</fpage>
<lpage>6724</lpage>
<?supplied-pmid 10586069?><pub-id pub-id-type="pmid">10586069</pub-id></element-citation></ref><ref id="B62-antibiotics-03-00540"><label>62.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Jia</surname><given-names>H.P.</given-names></name><name><surname>Zhao</surname><given-names>C.</given-names></name><name><surname>Heng</surname><given-names>H.H.</given-names></name><name><surname>Schutte</surname><given-names>B.C.</given-names></name><name><surname>McCray</surname><given-names>P.B.</given-names><suffix>Jr.</suffix></name><name><surname>Ganz</surname><given-names>T.</given-names></name></person-group>
<article-title>Structure and mapping of the human beta-defensin HBD-2 gene and its expression at sites of inflammation</article-title>
<source>Gene</source>
<year>1998</year>
<volume>222</volume>
<fpage>237</fpage>
<lpage>244</lpage>
<pub-id pub-id-type="doi">10.1016/S0378-1119(98)00480-6</pub-id>
<?supplied-pmid 9831658?><pub-id pub-id-type="pmid">9831658</pub-id></element-citation></ref><ref id="B63-antibiotics-03-00540"><label>63.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chromek</surname><given-names>M.</given-names></name><name><surname>Slamova</surname><given-names>Z.</given-names></name><name><surname>Bergman</surname><given-names>P.</given-names></name><name><surname>Kovacs</surname><given-names>L.</given-names></name><name><surname>Podracka</surname><given-names>L.</given-names></name><name><surname>Ehren</surname><given-names>I.</given-names></name><name><surname>Hokfelt</surname><given-names>T.</given-names></name><name><surname>Gudmundsson</surname><given-names>G.H.</given-names></name><name><surname>Gallo</surname><given-names>R.L.</given-names></name><name><surname>Agerberth</surname><given-names>B.</given-names></name><etal/></person-group>
<article-title>The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection</article-title>
<source>Nat. Med.</source>
<year>2006</year>
<volume>12</volume>
<fpage>636</fpage>
<lpage>641</lpage>
<pub-id pub-id-type="doi">10.1038/nm1407</pub-id>
<?supplied-pmid 16751768?><pub-id pub-id-type="pmid">16751768</pub-id></element-citation></ref><ref id="B64-antibiotics-03-00540"><label>64.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hase</surname><given-names>K.</given-names></name><name><surname>Eckmann</surname><given-names>L.</given-names></name><name><surname>Leopard</surname><given-names>J.D.</given-names></name><name><surname>Varki</surname><given-names>N.</given-names></name><name><surname>Kagnoff</surname><given-names>M.F.</given-names></name></person-group>
<article-title>Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium</article-title>
<source>Infect. Immun.</source>
<year>2002</year>
<volume>70</volume>
<fpage>953</fpage>
<lpage>963</lpage>
<pub-id pub-id-type="doi">10.1128/IAI.70.2.953-963.2002</pub-id>
<?supplied-pmid 11796631?><pub-id pub-id-type="pmid">11796631</pub-id></element-citation></ref><ref id="B65-antibiotics-03-00540"><label>65.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Durr</surname><given-names>U.H.</given-names></name><name><surname>Sudheendra</surname><given-names>U.S.</given-names></name><name><surname>Ramamoorthy</surname><given-names>A.</given-names></name></person-group>
<article-title>Ll-37, the only human member of the cathelicidin family of antimicrobial peptides</article-title>
<source>Biochim. Biophys. Acta</source>
<year>2006</year>
<volume>1758</volume>
<fpage>1408</fpage>
<lpage>1425</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbamem.2006.03.030</pub-id>
<?supplied-pmid 16716248?><pub-id pub-id-type="pmid">16716248</pub-id></element-citation></ref><ref id="B66-antibiotics-03-00540"><label>66.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Canny</surname><given-names>G.</given-names></name><name><surname>Levy</surname><given-names>O.</given-names></name></person-group>
<article-title>Bactericidal/permeability-increasing protein (bpi) and bpi homologs at mucosal sites</article-title>
<source>Trends Immunol.</source>
<year>2008</year>
<volume>29</volume>
<fpage>541</fpage>
<lpage>547</lpage>
<pub-id pub-id-type="doi">10.1016/j.it.2008.07.012</pub-id>
<?supplied-pmid 18838299?><pub-id pub-id-type="pmid">18838299</pub-id></element-citation></ref><ref id="B67-antibiotics-03-00540"><label>67.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Falco</surname><given-names>A.</given-names></name><name><surname>Chico</surname><given-names>V.</given-names></name><name><surname>Marroqui</surname><given-names>L.</given-names></name><name><surname>Perez</surname><given-names>L.</given-names></name><name><surname>Coll</surname><given-names>J.M.</given-names></name><name><surname>Estepa</surname><given-names>A.</given-names></name></person-group>
<article-title>Expression and antiviral activity of a beta-defensin-like peptide identified in the rainbow trout (<italic>Oncorhynchus mykiss</italic>) EST sequences</article-title>
<source>Mol. Immunol.</source>
<year>2008</year>
<volume>45</volume>
<fpage>757</fpage>
<lpage>765</lpage>
<pub-id pub-id-type="doi">10.1016/j.molimm.2007.06.358</pub-id>
<?supplied-pmid 17692376?><pub-id pub-id-type="pmid">17692376</pub-id></element-citation></ref><ref id="B68-antibiotics-03-00540"><label>68.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Uzzell</surname><given-names>T.</given-names></name><name><surname>Stolzenberg</surname><given-names>E.D.</given-names></name><name><surname>Shinnar</surname><given-names>A.E.</given-names></name><name><surname>Zasloff</surname><given-names>M.</given-names></name></person-group>
<article-title>Hagfish intestinal antimicrobial peptides are ancient cathelicidins</article-title>
<source>Peptides</source>
<year>2003</year>
<volume>24</volume>
<fpage>1655</fpage>
<lpage>1667</lpage>
<pub-id pub-id-type="doi">10.1016/j.peptides.2003.08.024</pub-id>
<?supplied-pmid 15019197?><pub-id pub-id-type="pmid">15019197</pub-id></element-citation></ref><ref id="B69-antibiotics-03-00540"><label>69.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Douglas</surname><given-names>S.E.</given-names></name><name><surname>Gallant</surname><given-names>J.W.</given-names></name><name><surname>Liebscher</surname><given-names>R.S.</given-names></name><name><surname>Dacanay</surname><given-names>A.</given-names></name><name><surname>Tsoi</surname><given-names>S.C.</given-names></name></person-group>
<article-title>Identification and expression analysis of hepcidin-like antimicrobial peptides in bony fish</article-title>
<source>Dev. Comp. Immunol.</source>
<year>2003</year>
<volume>27</volume>
<fpage>589</fpage>
<lpage>601</lpage>
<pub-id pub-id-type="doi">10.1016/S0145-305X(03)00036-3</pub-id>
<?supplied-pmid 12697315?><pub-id pub-id-type="pmid">12697315</pub-id></element-citation></ref><ref id="B70-antibiotics-03-00540"><label>70.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cole</surname><given-names>A.M.</given-names></name><name><surname>Weis</surname><given-names>P.</given-names></name><name><surname>Diamond</surname><given-names>G.</given-names></name></person-group>
<article-title>Isolation and characterization of pleurocidin, an antimicrobial peptide in the skin secretions of winter flounder</article-title>
<source>J. Biol. Chem.</source>
<year>1997</year>
<volume>272</volume>
<fpage>12008</fpage>
<lpage>12013</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.272.18.12008</pub-id>
<?supplied-pmid 9115266?><pub-id pub-id-type="pmid">9115266</pub-id></element-citation></ref><ref id="B71-antibiotics-03-00540"><label>71.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Noga</surname><given-names>E.J.</given-names></name><name><surname>Silphaduang</surname><given-names>U.</given-names></name></person-group>
<article-title>Piscidins: A novel family of peptide antibiotics from fish</article-title>
<source>Drug News Perspect.</source>
<year>2003</year>
<volume>16</volume>
<fpage>87</fpage>
<lpage>92</lpage>
<pub-id pub-id-type="doi">10.1358/dnp.2003.16.2.829325</pub-id>
<?supplied-pmid 12792669?><pub-id pub-id-type="pmid">12792669</pub-id></element-citation></ref><ref id="B72-antibiotics-03-00540"><label>72.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Salerno</surname><given-names>G.</given-names></name><name><surname>Parrinello</surname><given-names>N.</given-names></name><name><surname>Roch</surname><given-names>P.</given-names></name><name><surname>Cammarata</surname><given-names>M.</given-names></name></person-group>
<article-title>cDNA sequence and tissue expression of an antimicrobial peptide, dicentracin; a new component of the moronecidin family isolated from head kidney leukocytes of sea bass, <italic>Dicentrarchus labrax</italic></article-title>
<source>Comp. Biochem. Physiol. B Biochem. Mol. Biol.</source>
<year>2007</year>
<volume>146</volume>
<fpage>521</fpage>
<lpage>529</lpage>
<pub-id pub-id-type="doi">10.1016/j.cbpb.2006.12.007</pub-id>
<?supplied-pmid 17292649?><pub-id pub-id-type="pmid">17292649</pub-id></element-citation></ref><ref id="B73-antibiotics-03-00540"><label>73.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Park</surname><given-names>I.Y.</given-names></name><name><surname>Park</surname><given-names>C.B.</given-names></name><name><surname>Kim</surname><given-names>M.S.</given-names></name><name><surname>Kim</surname><given-names>S.C.</given-names></name></person-group>
<article-title>Parasin I, an antimicrobial peptide derived from histone H2A in the catfish, <italic>Parasilurus asotus</italic></article-title>
<source>FEBS Lett.</source>
<year>1998</year>
<volume>437</volume>
<fpage>258</fpage>
<lpage>262</lpage>
<pub-id pub-id-type="doi">10.1016/S0014-5793(98)01238-1</pub-id>
<?supplied-pmid 9824303?><pub-id pub-id-type="pmid">9824303</pub-id></element-citation></ref><ref id="B74-antibiotics-03-00540"><label>74.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Birkemo</surname><given-names>G.A.</given-names></name><name><surname>Luders</surname><given-names>T.</given-names></name><name><surname>Andersen</surname><given-names>O.</given-names></name><name><surname>Nes</surname><given-names>I.F.</given-names></name><name><surname>Nissen-Meyer</surname><given-names>J.</given-names></name></person-group>
<article-title>Hipposin, a histone-derived antimicrobial peptide in Atlantic halibut (<italic>Hippoglossus hippoglossus</italic> L.)</article-title>
<source>Biochim. Biophys. Acta</source>
<year>2003</year>
<volume>1646</volume>
<fpage>207</fpage>
<lpage>215</lpage>
<pub-id pub-id-type="doi">10.1016/S1570-9639(03)00018-9</pub-id>
<?supplied-pmid 12637028?><pub-id pub-id-type="pmid">12637028</pub-id></element-citation></ref><ref id="B75-antibiotics-03-00540"><label>75.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Abd</surname><given-names>H.</given-names></name><name><surname>Saeed</surname><given-names>A.</given-names></name><name><surname>Weintraub</surname><given-names>A.</given-names></name><name><surname>Nair</surname><given-names>G.B.</given-names></name><name><surname>Sandstrom</surname><given-names>G.</given-names></name></person-group>
<article-title><italic>Vibrio cholerae</italic> O1 strains are facultative intracellular bacteria, able to survive and multiply symbiotically inside the aquatic free-living amoeba <italic>Acanthamoeba castellanii</italic></article-title>
<source>FEMS Microbiol. Ecol.</source>
<year>2007</year>
<volume>60</volume>
<fpage>33</fpage>
<lpage>39</lpage>
<pub-id pub-id-type="doi">10.1111/j.1574-6941.2006.00254.x</pub-id>
<?supplied-pmid 17381524?><pub-id pub-id-type="pmid">17381524</pub-id></element-citation></ref><ref id="B76-antibiotics-03-00540"><label>76.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Abd</surname><given-names>H.</given-names></name><name><surname>Valeru</surname><given-names>S.P.</given-names></name><name><surname>Sami</surname><given-names>S.M.</given-names></name><name><surname>Saeed</surname><given-names>A.</given-names></name><name><surname>Raychaudhuri</surname><given-names>S.</given-names></name><name><surname>Sandstrom</surname><given-names>G.</given-names></name></person-group>
<article-title>Interaction between <italic>Vibrio mimicus</italic> and <italic>Acanthamoeba castellanii</italic></article-title>
<source>Environ. Microbiol. Rep.</source>
<year>2010</year>
<volume>2</volume>
<fpage>166</fpage>
<lpage>171</lpage>
<pub-id pub-id-type="doi">10.1111/j.1758-2229.2009.00129.x</pub-id>
<?supplied-pmid 20454692?><pub-id pub-id-type="pmid">20454692</pub-id></element-citation></ref><ref id="B77-antibiotics-03-00540"><label>77.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Abd</surname><given-names>H.</given-names></name><name><surname>Weintraub</surname><given-names>A.</given-names></name><name><surname>Sandstrom</surname><given-names>G.</given-names></name></person-group>
<article-title>Intracellular survival and replication of <italic>Vibrio cholerae</italic> o139 in aquatic free-living amoebae</article-title>
<source>Environ. Microbiol.</source>
<year>2005</year>
<volume>7</volume>
<fpage>1003</fpage>
<lpage>1008</lpage>
<pub-id pub-id-type="doi">10.1111/j.1462-2920.2005.00771.x</pub-id>
<?supplied-pmid 15946296?><pub-id pub-id-type="pmid">15946296</pub-id></element-citation></ref><ref id="B78-antibiotics-03-00540"><label>78.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ormonde</surname><given-names>P.</given-names></name><name><surname>Horstedt</surname><given-names>P.</given-names></name><name><surname>O&#x02019;Toole</surname><given-names>R.</given-names></name><name><surname>Milton</surname><given-names>D.L.</given-names></name></person-group>
<article-title>Role of motility in adherence to and invasion of a fish cell line by <italic>Vibrio anguillarum</italic></article-title>
<source>J. Bacteriol.</source>
<year>2000</year>
<volume>182</volume>
<fpage>2326</fpage>
<lpage>2328</lpage>
<pub-id pub-id-type="doi">10.1128/JB.182.8.2326-2328.2000</pub-id>
<?supplied-pmid 10735880?><pub-id pub-id-type="pmid">10735880</pub-id></element-citation></ref><ref id="B79-antibiotics-03-00540"><label>79.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>X.H.</given-names></name><name><surname>Oon</surname><given-names>H.L.</given-names></name><name><surname>Ho</surname><given-names>G.W.</given-names></name><name><surname>Wong</surname><given-names>W.S.</given-names></name><name><surname>Lim</surname><given-names>T.M.</given-names></name><name><surname>Leung</surname><given-names>K.Y.</given-names></name></person-group>
<article-title>Internalization and cytotoxicity are important virulence mechanisms in <italic>vibrio</italic>-fish epithelial cell interactions</article-title>
<source>Microbiology</source>
<year>1998</year>
<volume>144</volume>
<fpage>2987</fpage>
<lpage>3002</lpage>
<pub-id pub-id-type="doi">10.1099/00221287-144-11-2987</pub-id>
<?supplied-pmid 9846734?><pub-id pub-id-type="pmid">9846734</pub-id></element-citation></ref><ref id="B80-antibiotics-03-00540"><label>80.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ganz</surname><given-names>T.</given-names></name></person-group>
<article-title>Defensins: Antimicrobial peptides of vertebrates</article-title>
<source>C. R. Biol.</source>
<year>2004</year>
<volume>327</volume>
<fpage>539</fpage>
<lpage>549</lpage>
<pub-id pub-id-type="doi">10.1016/j.crvi.2003.12.007</pub-id>
<?supplied-pmid 15330253?><pub-id pub-id-type="pmid">15330253</pub-id></element-citation></ref><ref id="B81-antibiotics-03-00540"><label>81.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Duits</surname><given-names>L.A.</given-names></name><name><surname>Ravensbergen</surname><given-names>B.</given-names></name><name><surname>Rademaker</surname><given-names>M.</given-names></name><name><surname>Hiemstra</surname><given-names>P.S.</given-names></name><name><surname>Nibbering</surname><given-names>P.H.</given-names></name></person-group>
<article-title>Expression of beta-defensin 1 and 2 mrna by human monocytes, macrophages and dendritic cells</article-title>
<source>Immunology</source>
<year>2002</year>
<volume>106</volume>
<fpage>517</fpage>
<lpage>525</lpage>
<pub-id pub-id-type="doi">10.1046/j.1365-2567.2002.01430.x</pub-id>
<?supplied-pmid 12153515?><pub-id pub-id-type="pmid">12153515</pub-id></element-citation></ref><ref id="B82-antibiotics-03-00540"><label>82.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>P.T.</given-names></name><name><surname>Modlin</surname><given-names>R.L.</given-names></name></person-group>
<article-title>Human macrophage host defense against <italic>Mycobacterium tuberculosis</italic></article-title>
<source>Curr. Opin. Immunol.</source>
<year>2008</year>
<volume>20</volume>
<fpage>371</fpage>
<lpage>376</lpage>
<pub-id pub-id-type="doi">10.1016/j.coi.2008.05.014</pub-id>
<?supplied-pmid 18602003?><pub-id pub-id-type="pmid">18602003</pub-id></element-citation></ref><ref id="B83-antibiotics-03-00540"><label>83.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>P.T.</given-names></name><name><surname>Stenger</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Wenzel</surname><given-names>L.</given-names></name><name><surname>Tan</surname><given-names>B.H.</given-names></name><name><surname>Krutzik</surname><given-names>S.R.</given-names></name><name><surname>Ochoa</surname><given-names>M.T.</given-names></name><name><surname>Schauber</surname><given-names>J.</given-names></name><name><surname>Wu</surname><given-names>K.</given-names></name><name><surname>Meinken</surname><given-names>C.</given-names></name><etal/></person-group>
<article-title>Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response</article-title>
<source>Science</source>
<year>2006</year>
<volume>311</volume>
<fpage>1770</fpage>
<lpage>1773</lpage>
<pub-id pub-id-type="doi">10.1126/science.1123933</pub-id>
<?supplied-pmid 16497887?><pub-id pub-id-type="pmid">16497887</pub-id></element-citation></ref><ref id="B84-antibiotics-03-00540"><label>84.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sonawane</surname><given-names>A.</given-names></name><name><surname>Santos</surname><given-names>J.C.</given-names></name><name><surname>Mishra</surname><given-names>B.B.</given-names></name><name><surname>Jena</surname><given-names>P.</given-names></name><name><surname>Progida</surname><given-names>C.</given-names></name><name><surname>Sorensen</surname><given-names>O.E.</given-names></name><name><surname>Gallo</surname><given-names>R.</given-names></name><name><surname>Appelberg</surname><given-names>R.</given-names></name><name><surname>Griffiths</surname><given-names>G.</given-names></name></person-group>
<article-title>Cathelicidin is involved in the intracellular killing of mycobacteria in macrophages</article-title>
<source>Cell. Microbiol.</source>
<year>2011</year>
<volume>13</volume>
<fpage>1601</fpage>
<lpage>1617</lpage>
<pub-id pub-id-type="doi">10.1111/j.1462-5822.2011.01644.x</pub-id>
<?supplied-pmid 21790937?><pub-id pub-id-type="pmid">21790937</pub-id></element-citation></ref><ref id="B85-antibiotics-03-00540"><label>85.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mulero</surname><given-names>I.</given-names></name><name><surname>Noga</surname><given-names>E.J.</given-names></name><name><surname>Meseguer</surname><given-names>J.</given-names></name><name><surname>Garcia-Ayala</surname><given-names>A.</given-names></name><name><surname>Mulero</surname><given-names>V.</given-names></name></person-group>
<article-title>The antimicrobial peptides piscidins are stored in the granules of professional phagocytic granulocytes of fish and are delivered to the bacteria-containing phagosome upon phagocytosis</article-title>
<source>Dev. Comp. Immunol.</source>
<year>2008</year>
<volume>32</volume>
<fpage>1531</fpage>
<lpage>1538</lpage>
<pub-id pub-id-type="doi">10.1016/j.dci.2008.05.015</pub-id>
<?supplied-pmid 18582499?><pub-id pub-id-type="pmid">18582499</pub-id></element-citation></ref><ref id="B86-antibiotics-03-00540"><label>86.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cuesta</surname><given-names>A.</given-names></name><name><surname>Meseguer</surname><given-names>J.</given-names></name><name><surname>Esteban</surname><given-names>M.A.</given-names></name></person-group>
<article-title>The antimicrobial peptide hepcidin exerts an important role in the innate immunity against bacteria in the bony fish <italic>Gilthead seabream</italic></article-title>
<source>Mol. Immunol.</source>
<year>2008</year>
<volume>45</volume>
<fpage>2333</fpage>
<lpage>2342</lpage>
<pub-id pub-id-type="doi">10.1016/j.molimm.2007.11.007</pub-id>
<?supplied-pmid 18164062?><pub-id pub-id-type="pmid">18164062</pub-id></element-citation></ref><ref id="B87-antibiotics-03-00540"><label>87.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rosa</surname><given-names>R.D.</given-names></name><name><surname>Santini</surname><given-names>A.</given-names></name><name><surname>Fievet</surname><given-names>J.</given-names></name><name><surname>Bulet</surname><given-names>P.</given-names></name><name><surname>Destoumieux-Garzon</surname><given-names>D.</given-names></name><name><surname>Bachere</surname><given-names>E.</given-names></name></person-group>
<article-title>Big defensins, a diverse family of antimicrobial peptides that follows different patterns of expression in hemocytes of the oyster <italic>Crassostrea gigas</italic></article-title>
<source>PLoS One</source>
<year>2011</year>
<volume>6</volume>
<fpage>e25594</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0025594</pub-id>
<?supplied-pmid 21980497?><pub-id pub-id-type="pmid">21980497</pub-id></element-citation></ref><ref id="B88-antibiotics-03-00540"><label>88.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Leippe</surname><given-names>M.</given-names></name><name><surname>Herbst</surname><given-names>R.</given-names></name></person-group>
<article-title>Ancient weapons for attack and defense: The pore-forming polypeptides of pathogenic enteric and free-living amoeboid protozoa</article-title>
<source>J. Eukaryot. Microbiol.</source>
<year>2004</year>
<volume>51</volume>
<fpage>516</fpage>
<lpage>521</lpage>
<pub-id pub-id-type="doi">10.1111/j.1550-7408.2004.tb00286.x</pub-id>
<?supplied-pmid 15537085?><pub-id pub-id-type="pmid">15537085</pub-id></element-citation></ref><ref id="B89-antibiotics-03-00540"><label>89.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sorensen</surname><given-names>O.</given-names></name><name><surname>Arnljots</surname><given-names>K.</given-names></name><name><surname>Cowland</surname><given-names>J.B.</given-names></name><name><surname>Bainton</surname><given-names>D.F.</given-names></name><name><surname>Borregaard</surname><given-names>N.</given-names></name></person-group>
<article-title>The human antibacterial cathelicidin, hCAP-18, is synthesized in myelocytes and metamyelocytes and localized to specific granules in neutrophils</article-title>
<source>Blood</source>
<year>1997</year>
<volume>90</volume>
<fpage>2796</fpage>
<lpage>2803</lpage>
<?supplied-pmid 9326247?><pub-id pub-id-type="pmid">9326247</pub-id></element-citation></ref><ref id="B90-antibiotics-03-00540"><label>90.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Agerberth</surname><given-names>B.</given-names></name><name><surname>Charo</surname><given-names>J.</given-names></name><name><surname>Werr</surname><given-names>J.</given-names></name><name><surname>Olsson</surname><given-names>B.</given-names></name><name><surname>Idali</surname><given-names>F.</given-names></name><name><surname>Lindbom</surname><given-names>L.</given-names></name><name><surname>Kiessling</surname><given-names>R.</given-names></name><name><surname>Jornvall</surname><given-names>H.</given-names></name><name><surname>Wigzell</surname><given-names>H.</given-names></name><name><surname>Gudmundsson</surname><given-names>G.H.</given-names></name></person-group>
<article-title>The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations</article-title>
<source>Blood</source>
<year>2000</year>
<volume>96</volume>
<fpage>3086</fpage>
<lpage>3093</lpage>
<?supplied-pmid 11049988?><pub-id pub-id-type="pmid">11049988</pub-id></element-citation></ref><ref id="B91-antibiotics-03-00540"><label>91.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Knutson</surname><given-names>M.D.</given-names></name><name><surname>Oukka</surname><given-names>M.</given-names></name><name><surname>Koss</surname><given-names>L.M.</given-names></name><name><surname>Aydemir</surname><given-names>F.</given-names></name><name><surname>Wessling-Resnick</surname><given-names>M.</given-names></name></person-group>
<article-title>Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin</article-title>
<source>Proc. Natl. Acad. Sci. USA</source>
<year>2005</year>
<volume>102</volume>
<fpage>1324</fpage>
<lpage>1328</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0409409102</pub-id>
<?supplied-pmid 15665091?><pub-id pub-id-type="pmid">15665091</pub-id></element-citation></ref><ref id="B92-antibiotics-03-00540"><label>92.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sow</surname><given-names>F.B.</given-names></name><name><surname>Florence</surname><given-names>W.C.</given-names></name><name><surname>Satoskar</surname><given-names>A.R.</given-names></name><name><surname>Schlesinger</surname><given-names>L.S.</given-names></name><name><surname>Zwilling</surname><given-names>B.S.</given-names></name><name><surname>Lafuse</surname><given-names>W.P.</given-names></name></person-group>
<article-title>Expression and localization of hepcidin in macrophages: A role in host defense against tuberculosis</article-title>
<source>J. Leukoc. Biol.</source>
<year>2007</year>
<volume>82</volume>
<fpage>934</fpage>
<lpage>945</lpage>
<pub-id pub-id-type="doi">10.1189/jlb.0407216</pub-id>
<?supplied-pmid 17609338?><pub-id pub-id-type="pmid">17609338</pub-id></element-citation></ref><ref id="B93-antibiotics-03-00540"><label>93.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Weiss</surname><given-names>J.</given-names></name><name><surname>Olsson</surname><given-names>I.</given-names></name></person-group>
<article-title>Cellular and subcellular localization of the bactericidal/permeability-increasing protein of neutrophils</article-title>
<source>Blood</source>
<year>1987</year>
<volume>69</volume>
<fpage>652</fpage>
<lpage>659</lpage>
<?supplied-pmid 3801674?><pub-id pub-id-type="pmid">3801674</pub-id></element-citation></ref><ref id="B94-antibiotics-03-00540"><label>94.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Calafat</surname><given-names>J.</given-names></name><name><surname>Janssen</surname><given-names>H.</given-names></name><name><surname>Tool</surname><given-names>A.</given-names></name><name><surname>Dentener</surname><given-names>M.A.</given-names></name><name><surname>Knol</surname><given-names>E.F.</given-names></name><name><surname>Rosenberg</surname><given-names>H.F.</given-names></name><name><surname>Egesten</surname><given-names>A.</given-names></name></person-group>
<article-title>The bactericidal/permeability-increasing protein (bpi) is present in specific granules of human eosinophils</article-title>
<source>Blood</source>
<year>1998</year>
<volume>91</volume>
<fpage>4770</fpage>
<lpage>4775</lpage>
<?supplied-pmid 9616176?><pub-id pub-id-type="pmid">9616176</pub-id></element-citation></ref><ref id="B95-antibiotics-03-00540"><label>95.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Peschel</surname><given-names>A.</given-names></name><name><surname>Otto</surname><given-names>M.</given-names></name><name><surname>Jack</surname><given-names>R.W.</given-names></name><name><surname>Kalbacher</surname><given-names>H.</given-names></name><name><surname>Jung</surname><given-names>G.</given-names></name><name><surname>Gotz</surname><given-names>F.</given-names></name></person-group>
<article-title>Inactivation of the dlt operon in <italic>Staphylococcus aureus</italic> confers sensitivity to defensins, protegrins, and other antimicrobial peptides</article-title>
<source>J. Biol. Chem.</source>
<year>1999</year>
<volume>274</volume>
<fpage>8405</fpage>
<lpage>8410</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.274.13.8405</pub-id>
<?supplied-pmid 10085071?><pub-id pub-id-type="pmid">10085071</pub-id></element-citation></ref><ref id="B96-antibiotics-03-00540"><label>96.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Abi Khattar</surname><given-names>Z.</given-names></name><name><surname>Rejasse</surname><given-names>A.</given-names></name><name><surname>Destoumieux-Garzon</surname><given-names>D.</given-names></name><name><surname>Escoubas</surname><given-names>J.M.</given-names></name><name><surname>Sanchis</surname><given-names>V.</given-names></name><name><surname>Lereclus</surname><given-names>D.</given-names></name><name><surname>Givaudan</surname><given-names>A.</given-names></name><name><surname>Kallassy</surname><given-names>M.</given-names></name><name><surname>Nielsen-Leroux</surname><given-names>C.</given-names></name><name><surname>Gaudriault</surname><given-names>S.</given-names></name></person-group>
<article-title>The dlt operon of <italic>Bacillus cereus</italic> is required for resistance to cationic antimicrobial peptides and for virulence in insects</article-title>
<source>J. Bacteriol.</source>
<year>2009</year>
<volume>191</volume>
<fpage>7063</fpage>
<lpage>7073</lpage>
<pub-id pub-id-type="doi">10.1128/JB.00892-09</pub-id>
<?supplied-pmid 19767427?><pub-id pub-id-type="pmid">19767427</pub-id></element-citation></ref><ref id="B97-antibiotics-03-00540"><label>97.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Roy</surname><given-names>H.</given-names></name></person-group>
<article-title>Tuning the properties of the bacterial membrane with aminoacylated phosphatidylglycerol</article-title>
<source>IUBMB Life</source>
<year>2009</year>
<volume>61</volume>
<fpage>940</fpage>
<lpage>953</lpage>
<pub-id pub-id-type="doi">10.1002/iub.240</pub-id>
<?supplied-pmid 19787708?><pub-id pub-id-type="pmid">19787708</pub-id></element-citation></ref><ref id="B98-antibiotics-03-00540"><label>98.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Raetz</surname><given-names>C.R.</given-names></name><name><surname>Whitfield</surname><given-names>C.</given-names></name></person-group>
<article-title>Lipopolysaccharide endotoxins</article-title>
<source>Annu. Rev. Biochem.</source>
<year>2002</year>
<volume>71</volume>
<fpage>635</fpage>
<lpage>700</lpage>
<pub-id pub-id-type="doi">10.1146/annurev.biochem.71.110601.135414</pub-id>
<?supplied-pmid 12045108?><pub-id pub-id-type="pmid">12045108</pub-id></element-citation></ref><ref id="B99-antibiotics-03-00540"><label>99.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hankins</surname><given-names>J.V.</given-names></name><name><surname>Madsen</surname><given-names>J.A.</given-names></name><name><surname>Giles</surname><given-names>D.K.</given-names></name><name><surname>Childers</surname><given-names>B.M.</given-names></name><name><surname>Klose</surname><given-names>K.E.</given-names></name><name><surname>Brodbelt</surname><given-names>J.S.</given-names></name><name><surname>Trent</surname><given-names>M.S.</given-names></name></person-group>
<article-title>Elucidation of a novel <italic>Vibrio cholerae</italic> lipid a secondary hydroxy-acyltransferase and its role in innate immune recognition</article-title>
<source>Mol. Microbiol.</source>
<year>2011</year>
<volume>81</volume>
<fpage>1313</fpage>
<lpage>1329</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2958.2011.07765.x</pub-id>
<?supplied-pmid 21752109?><pub-id pub-id-type="pmid">21752109</pub-id></element-citation></ref><ref id="B100-antibiotics-03-00540"><label>100.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Phillips</surname><given-names>N.J.</given-names></name><name><surname>Adin</surname><given-names>D.M.</given-names></name><name><surname>Stabb</surname><given-names>E.V.</given-names></name><name><surname>McFall-Ngai</surname><given-names>M.J.</given-names></name><name><surname>Apicella</surname><given-names>M.A.</given-names></name><name><surname>Gibson</surname><given-names>B.W.</given-names></name></person-group>
<article-title>The lipid a from <italic>Vibrio fischeri</italic> lipopolysaccharide: A unique structure bearing a phosphoglycerol moiety</article-title>
<source>J. Biol. Chem.</source>
<year>2011</year>
<volume>286</volume>
<fpage>21203</fpage>
<lpage>21219</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M111.239475</pub-id>
<?supplied-pmid 21498521?><pub-id pub-id-type="pmid">21498521</pub-id></element-citation></ref><ref id="B101-antibiotics-03-00540"><label>101.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hankins</surname><given-names>J.V.</given-names></name><name><surname>Madsen</surname><given-names>J.A.</given-names></name><name><surname>Giles</surname><given-names>D.K.</given-names></name><name><surname>Brodbelt</surname><given-names>J.S.</given-names></name><name><surname>Trent</surname><given-names>M.S.</given-names></name></person-group>
<article-title>Amino acid addition to <italic>Vibrio cholerae</italic> lps establishes a link between surface remodeling in Gram-positive and Gram-negative bacteria</article-title>
<source>Proc. Natl. Acad. Sci. USA</source>
<year>2012</year>
<volume>109</volume>
<fpage>8722</fpage>
<lpage>8727</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1201313109</pub-id>
<?supplied-pmid 22589301?><pub-id pub-id-type="pmid">22589301</pub-id></element-citation></ref><ref id="B102-antibiotics-03-00540"><label>102.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Guilhelmelli</surname><given-names>F.</given-names></name><name><surname>Vilela</surname><given-names>N.</given-names></name><name><surname>Albuquerque</surname><given-names>P.</given-names></name><name><surname>Derengowski Lda</surname><given-names>S.</given-names></name><name><surname>Silva-Pereira</surname><given-names>I.</given-names></name><name><surname>Kyaw</surname><given-names>C.M.</given-names></name></person-group>
<article-title>Antibiotic development challenges: The various mechanisms of action of antimicrobial peptides and of bacterial resistance</article-title>
<source>Front. Microbiol.</source>
<year>2013</year>
<volume>4</volume>
<fpage>e353</fpage>
<pub-id pub-id-type="doi">10.3389/fmicb.2013.00353</pub-id>
</element-citation></ref><ref id="B103-antibiotics-03-00540"><label>103.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Needham</surname><given-names>B.D.</given-names></name><name><surname>Trent</surname><given-names>M.S.</given-names></name></person-group>
<article-title>Fortifying the barrier: The impact of lipid a remodelling on bacterial pathogenesis</article-title>
<source>Nat. Rev. Microbiol.</source>
<year>2013</year>
<volume>11</volume>
<fpage>467</fpage>
<lpage>481</lpage>
<pub-id pub-id-type="doi">10.1038/nrmicro3047</pub-id>
<?supplied-pmid 23748343?><pub-id pub-id-type="pmid">23748343</pub-id></element-citation></ref><ref id="B104-antibiotics-03-00540"><label>104.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Matson</surname><given-names>J.S.</given-names></name><name><surname>Yoo</surname><given-names>H.J.</given-names></name><name><surname>Hakansson</surname><given-names>K.</given-names></name><name><surname>Dirita</surname><given-names>V.J.</given-names></name></person-group>
<article-title>Polymyxin B resistance in El Tor <italic>Vibrio cholerae</italic> requires lipid acylation catalyzed by msbb</article-title>
<source>J. Bacteriol.</source>
<year>2010</year>
<volume>192</volume>
<fpage>2044</fpage>
<lpage>2052</lpage>
<pub-id pub-id-type="doi">10.1128/JB.00023-10</pub-id>
<?supplied-pmid 20154134?><pub-id pub-id-type="pmid">20154134</pub-id></element-citation></ref><ref id="B105-antibiotics-03-00540"><label>105.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Guo</surname><given-names>L.</given-names></name><name><surname>Lim</surname><given-names>K.B.</given-names></name><name><surname>Gunn</surname><given-names>J.S.</given-names></name><name><surname>Bainbridge</surname><given-names>B.</given-names></name><name><surname>Darveau</surname><given-names>R.P.</given-names></name><name><surname>Hackett</surname><given-names>M.</given-names></name><name><surname>Miller</surname><given-names>S.I.</given-names></name></person-group>
<article-title>Regulation of lipid a modifications by <italic>Salmonella typhimurium</italic> virulence genes <italic>phoP-phoQ</italic></article-title>
<source>Science</source>
<year>1997</year>
<volume>276</volume>
<fpage>250</fpage>
<lpage>253</lpage>
<pub-id pub-id-type="doi">10.1126/science.276.5310.250</pub-id>
<?supplied-pmid 9092473?><pub-id pub-id-type="pmid">9092473</pub-id></element-citation></ref><ref id="B106-antibiotics-03-00540"><label>106.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dalebroux</surname><given-names>Z.D.</given-names></name><name><surname>Miller</surname><given-names>S.I.</given-names></name></person-group>
<article-title><italic>Salmonellae</italic> phopq regulation of the outer membrane to resist innate immunity</article-title>
<source>Curr. Opin. Microbiol.</source>
<year>2014</year>
<volume>17</volume>
<fpage>106</fpage>
<lpage>113</lpage>
<pub-id pub-id-type="doi">10.1016/j.mib.2013.12.005</pub-id>
<?supplied-pmid 24531506?><pub-id pub-id-type="pmid">24531506</pub-id></element-citation></ref><ref id="B107-antibiotics-03-00540"><label>107.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bashyam</surname><given-names>M.D.</given-names></name><name><surname>Hasnain</surname><given-names>S.E.</given-names></name></person-group>
<article-title>The extracytoplasmic function sigma factors: Role in bacterial pathogenesis</article-title>
<source>Infect. Genet. Evol.</source>
<year>2004</year>
<volume>4</volume>
<fpage>301</fpage>
<lpage>308</lpage>
<pub-id pub-id-type="doi">10.1016/j.meegid.2004.04.003</pub-id>
<?supplied-pmid 15374527?><pub-id pub-id-type="pmid">15374527</pub-id></element-citation></ref><ref id="B108-antibiotics-03-00540"><label>108.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Davis</surname><given-names>B.M.</given-names></name><name><surname>Waldor</surname><given-names>M.K.</given-names></name></person-group>
<article-title>High-throughput sequencing reveals suppressors of <italic>Vibrio cholerae</italic>
<italic>rpoe</italic> mutations: One fewer porin is enough</article-title>
<source>Nucleic Acids Res.</source>
<year>2009</year>
<volume>37</volume>
<fpage>5757</fpage>
<lpage>5767</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkp568</pub-id>
<?supplied-pmid 19620211?><pub-id pub-id-type="pmid">19620211</pub-id></element-citation></ref><ref id="B109-antibiotics-03-00540"><label>109.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mathur</surname><given-names>J.</given-names></name><name><surname>Davis</surname><given-names>B.M.</given-names></name><name><surname>Waldor</surname><given-names>M.K.</given-names></name></person-group>
<article-title>Antimicrobial peptides activate the <italic>Vibrio cholerae</italic> sigmae regulon through an OmpU-dependent signalling pathway</article-title>
<source>Mol. Microbiol.</source>
<year>2007</year>
<volume>63</volume>
<fpage>848</fpage>
<lpage>858</lpage>
<?supplied-pmid 17181782?><pub-id pub-id-type="pmid">17181782</pub-id></element-citation></ref><ref id="B110-antibiotics-03-00540"><label>110.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mathur</surname><given-names>J.</given-names></name><name><surname>Waldor</surname><given-names>M.K.</given-names></name></person-group>
<article-title>The <italic>Vibrio cholerae</italic> ToxR-regulated porin OmpU confers resistance to antimicrobial peptides</article-title>
<source>Infect. Immun.</source>
<year>2004</year>
<volume>72</volume>
<fpage>3577</fpage>
<lpage>3583</lpage>
<pub-id pub-id-type="doi">10.1128/IAI.72.6.3577-3583.2004</pub-id>
<?supplied-pmid 15155667?><pub-id pub-id-type="pmid">15155667</pub-id></element-citation></ref><ref id="B111-antibiotics-03-00540"><label>111.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Duperthuy</surname><given-names>M.</given-names></name><name><surname>Binesse</surname><given-names>J.</given-names></name><name><surname>Le Roux</surname><given-names>F.</given-names></name><name><surname>Romestand</surname><given-names>B.</given-names></name><name><surname>Caro</surname><given-names>A.</given-names></name><name><surname>Got</surname><given-names>P.</given-names></name><name><surname>Givaudan</surname><given-names>A.</given-names></name><name><surname>Mazel</surname><given-names>D.</given-names></name><name><surname>Bachere</surname><given-names>E.</given-names></name><name><surname>Destoumieux-Garzon</surname><given-names>D.</given-names></name></person-group>
<article-title>The major outer membrane protein ompu of <italic>Vibrio splendidus</italic> contributes to host antimicrobial peptide resistance and is required for virulence in the oyster <italic>Crassostrea gigas</italic></article-title>
<source>Environ. Microbiol.</source>
<year>2010</year>
<volume>12</volume>
<fpage>951</fpage>
<lpage>963</lpage>
<pub-id pub-id-type="doi">10.1111/j.1462-2920.2009.02138.x</pub-id>
<?supplied-pmid 20074236?><pub-id pub-id-type="pmid">20074236</pub-id></element-citation></ref><ref id="B112-antibiotics-03-00540"><label>112.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Beveridge</surname><given-names>T.J.</given-names></name></person-group>
<article-title>Structures of Gram-negative cell walls and their derived membrane vesicles</article-title>
<source>J. Bacteriol.</source>
<year>1999</year>
<volume>181</volume>
<fpage>4725</fpage>
<lpage>4733</lpage>
<?supplied-pmid 10438737?><pub-id pub-id-type="pmid">10438737</pub-id></element-citation></ref><ref id="B113-antibiotics-03-00540"><label>113.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wai</surname><given-names>S.N.</given-names></name><name><surname>Takade</surname><given-names>A.</given-names></name><name><surname>Amako</surname><given-names>K.</given-names></name></person-group>
<article-title>The release of outer membrane vesicles from the strains of enterotoxigenic <italic>Escherichia coli</italic></article-title>
<source>Microbiol. Immunol.</source>
<year>1995</year>
<volume>39</volume>
<fpage>451</fpage>
<lpage>456</lpage>
<pub-id pub-id-type="doi">10.1111/j.1348-0421.1995.tb02228.x</pub-id>
<?supplied-pmid 8569529?><pub-id pub-id-type="pmid">8569529</pub-id></element-citation></ref><ref id="B114-antibiotics-03-00540"><label>114.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kulp</surname><given-names>A.</given-names></name><name><surname>Kuehn</surname><given-names>M.J.</given-names></name></person-group>
<article-title>Biological functions and biogenesis of secreted bacterial outer membrane vesicles</article-title>
<source>Annu. Rev. Microbiol.</source>
<year>2010</year>
<volume>64</volume>
<fpage>163</fpage>
<lpage>184</lpage>
<pub-id pub-id-type="doi">10.1146/annurev.micro.091208.073413</pub-id>
<?supplied-pmid 20825345?><pub-id pub-id-type="pmid">20825345</pub-id></element-citation></ref><ref id="B115-antibiotics-03-00540"><label>115.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chatterjee</surname><given-names>S.N.</given-names></name><name><surname>Das</surname><given-names>J.</given-names></name></person-group>
<article-title>Electron microscopic observations on the excretion of cell-wall material by <italic>Vibrio cholerae</italic></article-title>
<source>J. Gen. Microbiol.</source>
<year>1967</year>
<volume>49</volume>
<fpage>1</fpage>
<lpage>11</lpage>
<pub-id pub-id-type="doi">10.1099/00221287-49-1-1</pub-id>
<?supplied-pmid 4168882?><pub-id pub-id-type="pmid">4168882</pub-id></element-citation></ref><ref id="B116-antibiotics-03-00540"><label>116.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hong</surname><given-names>G.E.</given-names></name><name><surname>Kim</surname><given-names>D.G.</given-names></name><name><surname>Park</surname><given-names>E.M.</given-names></name><name><surname>Nam</surname><given-names>B.H.</given-names></name><name><surname>Kim</surname><given-names>Y.O.</given-names></name><name><surname>Kong</surname><given-names>I.S.</given-names></name></person-group>
<article-title>Identification of <italic>Vibrio anguillarum</italic> outer membrane vesicles related to immunostimulation in the Japanese flounder, <italic>Paralichthys olivaceus</italic></article-title>
<source>Biosci. Biotech. Biochem.</source>
<year>2009</year>
<volume>73</volume>
<fpage>437</fpage>
<lpage>439</lpage>
<pub-id pub-id-type="doi">10.1271/bbb.80580</pub-id>
</element-citation></ref><ref id="B117-antibiotics-03-00540"><label>117.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kim</surname><given-names>Y.R.</given-names></name><name><surname>Kim</surname><given-names>B.U.</given-names></name><name><surname>Kim</surname><given-names>S.Y.</given-names></name><name><surname>Kim</surname><given-names>C.M.</given-names></name><name><surname>Na</surname><given-names>H.S.</given-names></name><name><surname>Koh</surname><given-names>J.T.</given-names></name><name><surname>Choy</surname><given-names>H.E.</given-names></name><name><surname>Rhee</surname><given-names>J.H.</given-names></name><name><surname>Lee</surname><given-names>S.E.</given-names></name></person-group>
<article-title>Outer membrane vesicles of <italic>Vibrio vulnificus</italic> deliver cytolysin-hemolysin VvhA into epithelial cells to induce cytotoxicity</article-title>
<source>Biochem. Biophys. Res. Commun.</source>
<year>2010</year>
<volume>399</volume>
<fpage>607</fpage>
<lpage>612</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbrc.2010.07.122</pub-id>
<?supplied-pmid 20682286?><pub-id pub-id-type="pmid">20682286</pub-id></element-citation></ref><ref id="B118-antibiotics-03-00540"><label>118.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Manning</surname><given-names>A.J.</given-names></name><name><surname>Kuehn</surname><given-names>M.J.</given-names></name></person-group>
<article-title>Functional advantages conferred by extracellular prokaryotic membrane vesicles</article-title>
<source>J. Mol. Microbiol. Biotechnol.</source>
<year>2013</year>
<volume>23</volume>
<fpage>131</fpage>
<lpage>141</lpage>
<pub-id pub-id-type="doi">10.1159/000346548</pub-id>
<?supplied-pmid 23615201?><pub-id pub-id-type="pmid">23615201</pub-id></element-citation></ref><ref id="B119-antibiotics-03-00540"><label>119.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Duperthuy</surname><given-names>M.</given-names></name><name><surname>Sjostrom</surname><given-names>A.E.</given-names></name><name><surname>Sabharwal</surname><given-names>D.</given-names></name><name><surname>Damghani</surname><given-names>F.</given-names></name><name><surname>Uhlin</surname><given-names>B.E.</given-names></name><name><surname>Wai</surname><given-names>S.N.</given-names></name></person-group>
<article-title>Role of the <italic>Vibrio cholerae</italic> matrix protein bap1 in cross-resistance to antimicrobial peptides</article-title>
<source>PLoS Pathog.</source>
<year>2013</year>
<volume>9</volume>
<fpage>e1003620</fpage>
<pub-id pub-id-type="doi">10.1371/journal.ppat.1003620</pub-id>
<?supplied-pmid 24098113?><pub-id pub-id-type="pmid">24098113</pub-id></element-citation></ref><ref id="B120-antibiotics-03-00540"><label>120.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vanhove</surname><given-names>A.S.</given-names></name><name><surname>Duperthuy</surname><given-names>M.</given-names></name><name><surname>Charriere</surname><given-names>G.M.</given-names></name><name><surname>Le Roux</surname><given-names>F.</given-names></name><name><surname>Goudenege</surname><given-names>D.</given-names></name><name><surname>Gourbal</surname><given-names>B.</given-names></name><name><surname>Kieffer-Jaquinod</surname><given-names>S.</given-names></name><name><surname>Coute</surname><given-names>Y.</given-names></name><name><surname>Wai</surname><given-names>S.N.</given-names></name><name><surname>Destoumieux-Garzon</surname><given-names>D.</given-names></name></person-group>
<article-title>Outer membrane vesicles are vehicles for the delivery of <italic>Vibrio tasmaniensis</italic> virulence factors to oyster immune cells</article-title>
<source>Environ. Microbiol.</source>
<year>2014</year>
<pub-id pub-id-type="doi">10.1111/1462-2920.12535</pub-id>
</element-citation></ref><ref id="B121-antibiotics-03-00540"><label>121.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Song</surname><given-names>T.</given-names></name><name><surname>Mika</surname><given-names>F.</given-names></name><name><surname>Lindmark</surname><given-names>B.</given-names></name><name><surname>Liu</surname><given-names>Z.</given-names></name><name><surname>Schild</surname><given-names>S.</given-names></name><name><surname>Bishop</surname><given-names>A.</given-names></name><name><surname>Zhu</surname><given-names>J.</given-names></name><name><surname>Camilli</surname><given-names>A.</given-names></name><name><surname>Johansson</surname><given-names>J.</given-names></name><name><surname>Vogel</surname><given-names>J.</given-names></name><etal/></person-group>
<article-title>A new <italic>Vibrio cholerae</italic> sRNA modulates colonization and affects release of outer membrane vesicles</article-title>
<source>Mol. Microbiol.</source>
<year>2008</year>
<volume>70</volume>
<fpage>100</fpage>
<lpage>111</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2958.2008.06392.x</pub-id>
<?supplied-pmid 18681937?><pub-id pub-id-type="pmid">18681937</pub-id></element-citation></ref><ref id="B122-antibiotics-03-00540"><label>122.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nikaido</surname><given-names>H.</given-names></name><name><surname>Pages</surname><given-names>J.M.</given-names></name></person-group>
<article-title>Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria</article-title>
<source>FEMS Microbiol. Rev.</source>
<year>2012</year>
<volume>36</volume>
<fpage>340</fpage>
<lpage>363</lpage>
<pub-id pub-id-type="doi">10.1111/j.1574-6976.2011.00290.x</pub-id>
<?supplied-pmid 21707670?><pub-id pub-id-type="pmid">21707670</pub-id></element-citation></ref><ref id="B123-antibiotics-03-00540"><label>123.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Piddock</surname><given-names>L.J.</given-names></name></person-group>
<article-title>Multidrug-resistance efflux pumps&#x02014;Not just for resistance</article-title>
<source>Nat. Rev. Microbiol.</source>
<year>2006</year>
<volume>4</volume>
<fpage>629</fpage>
<lpage>636</lpage>
<pub-id pub-id-type="doi">10.1038/nrmicro1464</pub-id>
<?supplied-pmid 16845433?><pub-id pub-id-type="pmid">16845433</pub-id></element-citation></ref><ref id="B124-antibiotics-03-00540"><label>124.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Putman</surname><given-names>M.</given-names></name><name><surname>van Veen</surname><given-names>H.W.</given-names></name><name><surname>Konings</surname><given-names>W.N.</given-names></name></person-group>
<article-title>Molecular properties of bacterial multidrug transporters</article-title>
<source>Microbiol. Mol. Biol. Rev.</source>
<year>2000</year>
<volume>64</volume>
<fpage>672</fpage>
<lpage>693</lpage>
<pub-id pub-id-type="doi">10.1128/MMBR.64.4.672-693.2000</pub-id>
<?supplied-pmid 11104814?><pub-id pub-id-type="pmid">11104814</pub-id></element-citation></ref><ref id="B125-antibiotics-03-00540"><label>125.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hinchliffe</surname><given-names>P.</given-names></name><name><surname>Symmons</surname><given-names>M.F.</given-names></name><name><surname>Hughes</surname><given-names>C.</given-names></name><name><surname>Koronakis</surname><given-names>V.</given-names></name></person-group>
<article-title>Structure and operation of bacterial tripartite pumps</article-title>
<source>Annu. Rev. Microbiol.</source>
<year>2013</year>
<volume>67</volume>
<fpage>221</fpage>
<lpage>242</lpage>
<pub-id pub-id-type="doi">10.1146/annurev-micro-092412-155718</pub-id>
<?supplied-pmid 23808339?><pub-id pub-id-type="pmid">23808339</pub-id></element-citation></ref><ref id="B126-antibiotics-03-00540"><label>126.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bina</surname><given-names>J.E.</given-names></name><name><surname>Mekalanos</surname><given-names>J.J.</given-names></name></person-group>
<article-title><italic>Vibrio cholerae</italic> tolc is required for bile resistance and colonization</article-title>
<source>Infect. Immun.</source>
<year>2001</year>
<volume>69</volume>
<fpage>4681</fpage>
<lpage>4685</lpage>
<pub-id pub-id-type="doi">10.1128/IAI.69.7.4681-4685.2001</pub-id>
<?supplied-pmid 11402016?><pub-id pub-id-type="pmid">11402016</pub-id></element-citation></ref><ref id="B127-antibiotics-03-00540"><label>127.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bina</surname><given-names>X.R.</given-names></name><name><surname>Provenzano</surname><given-names>D.</given-names></name><name><surname>Nguyen</surname><given-names>N.</given-names></name><name><surname>Bina</surname><given-names>J.E.</given-names></name></person-group>
<article-title><italic>Vibrio cholerae</italic> RND family efflux systems are required for antimicrobial resistance, optimal virulence factor production, and colonization of the infant mouse small intestine</article-title>
<source>Infect. Immun.</source>
<year>2008</year>
<volume>76</volume>
<fpage>3595</fpage>
<lpage>3605</lpage>
<pub-id pub-id-type="doi">10.1128/IAI.01620-07</pub-id>
<?supplied-pmid 18490456?><pub-id pub-id-type="pmid">18490456</pub-id></element-citation></ref><ref id="B128-antibiotics-03-00540"><label>128.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nikaido</surname><given-names>H.</given-names></name><name><surname>Zgurskaya</surname><given-names>H.I.</given-names></name></person-group>
<article-title>AcrAB and related multidrug efflux pumps of <italic>Escherichia coli</italic></article-title>
<source>J. Mol. Microbiol. Biotechnol.</source>
<year>2001</year>
<volume>3</volume>
<fpage>215</fpage>
<lpage>218</lpage>
<?supplied-pmid 11321576?><pub-id pub-id-type="pmid">11321576</pub-id></element-citation></ref><ref id="B129-antibiotics-03-00540"><label>129.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Buckley</surname><given-names>A.M.</given-names></name><name><surname>Webber</surname><given-names>M.A.</given-names></name><name><surname>Cooles</surname><given-names>S.</given-names></name><name><surname>Randall</surname><given-names>L.P.</given-names></name><name><surname>La Ragione</surname><given-names>R.M.</given-names></name><name><surname>Woodward</surname><given-names>M.J.</given-names></name><name><surname>Piddock</surname><given-names>L.J.</given-names></name></person-group>
<article-title>The AcrAB-TolC efflux system of <italic>Salmonella enterica</italic> serovar Typhimurium plays a role in pathogenesis</article-title>
<source>Cell. Microbiol.</source>
<year>2006</year>
<volume>8</volume>
<fpage>847</fpage>
<lpage>856</lpage>
<pub-id pub-id-type="doi">10.1111/j.1462-5822.2005.00671.x</pub-id>
<?supplied-pmid 16611233?><pub-id pub-id-type="pmid">16611233</pub-id></element-citation></ref><ref id="B130-antibiotics-03-00540"><label>130.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Poole</surname><given-names>K.</given-names></name></person-group>
<article-title>Multidrug efflux pumps and antimicrobial resistance in <italic>Pseudomonas aeruginosa</italic> and related organisms</article-title>
<source>J. Mol. Microbiol. Biotechnol.</source>
<year>2001</year>
<volume>3</volume>
<fpage>255</fpage>
<lpage>264</lpage>
<?supplied-pmid 11321581?><pub-id pub-id-type="pmid">11321581</pub-id></element-citation></ref><ref id="B131-antibiotics-03-00540"><label>131.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kitaoka</surname><given-names>M.</given-names></name><name><surname>Miyata</surname><given-names>S.T.</given-names></name><name><surname>Unterweger</surname><given-names>D.</given-names></name><name><surname>Pukatzki</surname><given-names>S.</given-names></name></person-group>
<article-title>Antibiotic resistance mechanisms of <italic>Vibrio cholerae</italic></article-title>
<source>J. Med. Microbiol.</source>
<year>2011</year>
<volume>60</volume>
<fpage>397</fpage>
<lpage>407</lpage>
<pub-id pub-id-type="doi">10.1099/jmm.0.023051-0</pub-id>
<?supplied-pmid 21252269?><pub-id pub-id-type="pmid">21252269</pub-id></element-citation></ref><ref id="B132-antibiotics-03-00540"><label>132.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bina</surname><given-names>J.E.</given-names></name><name><surname>Provenzano</surname><given-names>D.</given-names></name><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Bina</surname><given-names>X.R.</given-names></name><name><surname>Mekalanos</surname><given-names>J.J.</given-names></name></person-group>
<article-title>Characterization of the <italic>Vibrio cholerae</italic>
<italic>vexab</italic> and <italic>vexcd</italic> efflux systems</article-title>
<source>Arch. Microbiol.</source>
<year>2006</year>
<volume>186</volume>
<fpage>171</fpage>
<lpage>181</lpage>
<pub-id pub-id-type="doi">10.1007/s00203-006-0133-5</pub-id>
<?supplied-pmid 16804679?><pub-id pub-id-type="pmid">16804679</pub-id></element-citation></ref><ref id="B133-antibiotics-03-00540"><label>133.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Taylor</surname><given-names>D.L.</given-names></name><name><surname>Bina</surname><given-names>X.R.</given-names></name><name><surname>Bina</surname><given-names>J.E.</given-names></name></person-group>
<article-title><italic>Vibrio cholerae</italic> vexh encodes a multiple drug efflux pump that contributes to the production of cholera toxin and the toxin co-regulated pilus</article-title>
<source>PLoS One</source>
<year>2012</year>
<volume>7</volume>
<fpage>e38208</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0038208</pub-id>
<?supplied-pmid 22666485?><pub-id pub-id-type="pmid">22666485</pub-id></element-citation></ref><ref id="B134-antibiotics-03-00540"><label>134.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shen</surname><given-names>C.J.</given-names></name><name><surname>Kuo</surname><given-names>T.Y.</given-names></name><name><surname>Lin</surname><given-names>C.C.</given-names></name><name><surname>Chow</surname><given-names>L.P.</given-names></name><name><surname>Chen</surname><given-names>W.J.</given-names></name></person-group>
<article-title>Proteomic identification of membrane proteins regulating antimicrobial peptide resistance in <italic>Vibrio parahaemolyticus</italic></article-title>
<source>J. Appl. Microbiol.</source>
<year>2010</year>
<volume>108</volume>
<fpage>1398</fpage>
<lpage>1407</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2672.2009.04544.x</pub-id>
<?supplied-pmid 19796120?><pub-id pub-id-type="pmid">19796120</pub-id></element-citation></ref><ref id="B135-antibiotics-03-00540"><label>135.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y.C.</given-names></name><name><surname>Chuang</surname><given-names>Y.C.</given-names></name><name><surname>Chang</surname><given-names>C.C.</given-names></name><name><surname>Jeang</surname><given-names>C.L.</given-names></name><name><surname>Chang</surname><given-names>M.C.</given-names></name></person-group>
<article-title>A K<sup>+</sup> uptake protein, TrkA, is required for serum, protamine, and polymyxin B resistance in <italic>Vibrio vulnificus</italic></article-title>
<source>Infect. Immun.</source>
<year>2004</year>
<volume>72</volume>
<fpage>629</fpage>
<lpage>636</lpage>
<pub-id pub-id-type="doi">10.1128/IAI.72.2.629-636.2004</pub-id>
<?supplied-pmid 14742502?><pub-id pub-id-type="pmid">14742502</pub-id></element-citation></ref><ref id="B136-antibiotics-03-00540"><label>136.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bossemeyer</surname><given-names>D.</given-names></name><name><surname>Borchard</surname><given-names>A.</given-names></name><name><surname>Dosch</surname><given-names>D.C.</given-names></name><name><surname>Helmer</surname><given-names>G.C.</given-names></name><name><surname>Epstein</surname><given-names>W.</given-names></name><name><surname>Booth</surname><given-names>I.R.</given-names></name><name><surname>Bakker</surname><given-names>E.P.</given-names></name></person-group>
<article-title>K<sup>+</sup>-transport protein TrkA of <italic>Escherichia coli</italic> is a peripheral membrane protein that requires other trk gene products for attachment to the cytoplasmic membrane</article-title>
<source>J. Biol. Chem.</source>
<year>1989</year>
<volume>264</volume>
<fpage>16403</fpage>
<lpage>16410</lpage>
<?supplied-pmid 2674131?><pub-id pub-id-type="pmid">2674131</pub-id></element-citation></ref><ref id="B137-antibiotics-03-00540"><label>137.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chakraborty</surname><given-names>K.</given-names></name><name><surname>Ghosh</surname><given-names>S.</given-names></name><name><surname>Koley</surname><given-names>H.</given-names></name><name><surname>Mukhopadhyay</surname><given-names>A.K.</given-names></name><name><surname>Ramamurthy</surname><given-names>T.</given-names></name><name><surname>Saha</surname><given-names>D.R.</given-names></name><name><surname>Mukhopadhyay</surname><given-names>D.</given-names></name><name><surname>Roychowdhury</surname><given-names>S.</given-names></name><name><surname>Hamabata</surname><given-names>T.</given-names></name><name><surname>Takeda</surname><given-names>Y.</given-names></name><etal/></person-group>
<article-title>Bacterial exotoxins downregulate cathelicidin (hCAP-18/LL-37) and human beta-defensin 1 (HBD-1) expression in the intestinal epithelial cells</article-title>
<source>Cell. Microbiol.</source>
<year>2008</year>
<volume>10</volume>
<fpage>2520</fpage>
<lpage>2537</lpage>
<pub-id pub-id-type="doi">10.1111/j.1462-5822.2008.01227.x</pub-id>
<?supplied-pmid 18717821?><pub-id pub-id-type="pmid">18717821</pub-id></element-citation></ref><ref id="B138-antibiotics-03-00540"><label>138.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shirin</surname><given-names>T.</given-names></name><name><surname>Rahman</surname><given-names>A.</given-names></name><name><surname>Danielsson</surname><given-names>A.</given-names></name><name><surname>Uddin</surname><given-names>T.</given-names></name><name><surname>Bhuyian</surname><given-names>T.R.</given-names></name><name><surname>Sheikh</surname><given-names>A.</given-names></name><name><surname>Qadri</surname><given-names>S.S.</given-names></name><name><surname>Qadri</surname><given-names>F.</given-names></name><name><surname>Hammarstrom</surname><given-names>M.L.</given-names></name></person-group>
<article-title>Antimicrobial peptides in the duodenum at the acute and convalescent stages in patients with diarrhea due to <italic>Vibrio cholerae</italic> o1 or enterotoxigenic <italic>Escherichia coli</italic> infection</article-title>
<source>Microbes Infect.</source>
<year>2011</year>
<volume>13</volume>
<fpage>1111</fpage>
<lpage>1120</lpage>
<pub-id pub-id-type="doi">10.1016/j.micinf.2011.06.014</pub-id>
<?supplied-pmid 21782033?><pub-id pub-id-type="pmid">21782033</pub-id></element-citation></ref><ref id="B139-antibiotics-03-00540"><label>139.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vidal-Dupiol</surname><given-names>J.</given-names></name><name><surname>Dheilly</surname><given-names>N.M.</given-names></name><name><surname>Rondon</surname><given-names>R.</given-names></name><name><surname>Grunau</surname><given-names>C.</given-names></name><name><surname>Cosseau</surname><given-names>C.</given-names></name><name><surname>Smith</surname><given-names>K.M.</given-names></name><name><surname>Freitag</surname><given-names>M.</given-names></name><name><surname>Adjeroud</surname><given-names>M.</given-names></name><name><surname>Mitta</surname><given-names>G.</given-names></name></person-group>
<article-title>Thermal stress triggers broad <italic>Pocillopora damicornis</italic> transcriptomic remodeling, while <italic>Vibrio coralliilyticus</italic> infection induces a more targeted immuno-suppression response</article-title>
<source>PLoS One</source>
<year>2014</year>
<pub-id pub-id-type="doi">10.1371/journal.pone.0107672</pub-id>
</element-citation></ref><ref id="B140-antibiotics-03-00540"><label>140.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Venier</surname><given-names>P.</given-names></name><name><surname>Varotto</surname><given-names>L.</given-names></name><name><surname>Rosani</surname><given-names>U.</given-names></name><name><surname>Millino</surname><given-names>C.</given-names></name><name><surname>Celegato</surname><given-names>B.</given-names></name><name><surname>Bernante</surname><given-names>F.</given-names></name><name><surname>Lanfranchi</surname><given-names>G.</given-names></name><name><surname>Novoa</surname><given-names>B.</given-names></name><name><surname>Roch</surname><given-names>P.</given-names></name><name><surname>Figueras</surname><given-names>A.</given-names></name><etal/></person-group>
<article-title>Insights into the innate immunity of the mediterranean mussel <italic>Mytilus galloprovincialis</italic></article-title>
<source>BMC Genomics</source>
<year>2011</year>
<volume>12</volume>
<fpage>e69</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2164-12-69</pub-id>
</element-citation></ref></ref-list></back></article>